<SEC-DOCUMENT>0000827054-23-000058.txt : 20230414
<SEC-HEADER>0000827054-23-000058.hdr.sgml : 20230414
<ACCEPTANCE-DATETIME>20230414172447
ACCESSION NUMBER:		0000827054-23-000058
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		14
CONFORMED PERIOD OF REPORT:	20230414
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20230414
DATE AS OF CHANGE:		20230414

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			MICROCHIP TECHNOLOGY INC
		CENTRAL INDEX KEY:			0000827054
		STANDARD INDUSTRIAL CLASSIFICATION:	SEMICONDUCTORS & RELATED DEVICES [3674]
		IRS NUMBER:				860629024
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			0331

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-21184
		FILM NUMBER:		23822142

	BUSINESS ADDRESS:	
		STREET 1:		2355 W CHANDLER BLVD
		CITY:			CHANDLER
		STATE:			AZ
		ZIP:			85224-6199
		BUSINESS PHONE:		480-792-7200

	MAIL ADDRESS:	
		STREET 1:		2355 WEST CHANDLER BLVD
		CITY:			CHANDLER
		STATE:			AZ
		ZIP:			85224-6199
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>mchp-20230414.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with Wdesk from Workiva--><!--Copyright 2023 Workiva--><!--r:cc2fc762-edf7-48fe-a50d-a2ddf87cd639,g:ae4f47c7-dfca-4233-8087-a9a33399c5b9,d:f97d4fd4815c408992fae0852e0bca4f--><html xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns="http://www.w3.org/1999/xhtml" xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>mchp-20230414</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="i829a3695c8e54b839f595b7e5e02de3f_D20230414-20230414" name="dei:EntityCentralIndexKey" id="f-21">0000827054</ix:nonNumeric><ix:nonNumeric contextRef="i829a3695c8e54b839f595b7e5e02de3f_D20230414-20230414" name="dei:AmendmentFlag" id="f-22">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="mchp-20230414.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="i829a3695c8e54b839f595b7e5e02de3f_D20230414-20230414"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000827054</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-04-14</xbrli:startDate><xbrli:endDate>2023-04-14</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="if97d4fd4815c408992fae0852e0bca4f_1"></div><div style="min-height:23.4pt;width:100%"><div><span><br/></span></div></div><div style="padding-left:103.5pt;padding-right:103.5pt;text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:15pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:15pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:13pt;font-weight:700;line-height:120%">Washington, D.C. 20549</span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:15pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="i829a3695c8e54b839f595b7e5e02de3f_D20230414-20230414" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric> </span></div><div style="text-align:center"><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">THE SECURITIES EXCHANGE ACT OF 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Date of Report (Date of earliest event reported)</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:13pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i829a3695c8e54b839f595b7e5e02de3f_D20230414-20230414" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">April 14, 2023</ix:nonNumeric></span></div><div style="margin-bottom:3pt;text-align:center"><span><br/></span></div><div style="margin-top:1pt;text-align:center"><img src="mchp-20230414_g1.jpg" alt="mlogoa10.jpg" style="height:101px;margin-bottom:5pt;vertical-align:text-bottom;width:358px"/></div><div style="margin-top:9pt;text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:15pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i829a3695c8e54b839f595b7e5e02de3f_D20230414-20230414" name="dei:EntityRegistrantName" id="f-3">MICROCHIP TECHNOLOGY INCORPORATED</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(Exact Name Of Registrant As Specified In Its Charter)</span></div><div style="margin-top:5pt;padding-left:102.37pt;padding-right:102.37pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline"><ix:nonNumeric contextRef="i829a3695c8e54b839f595b7e5e02de3f_D20230414-20230414" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline"><ix:nonNumeric contextRef="i829a3695c8e54b839f595b7e5e02de3f_D20230414-20230414" name="dei:EntityFileNumber" id="f-5">0-21184</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline"><ix:nonNumeric contextRef="i829a3695c8e54b839f595b7e5e02de3f_D20230414-20230414" name="dei:EntityTaxIdentificationNumber" id="f-6">86-0629024</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(State or other Jurisdiction of Incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(Commission File No.)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(IRS Employer Identification No.)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:104%"> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="i829a3695c8e54b839f595b7e5e02de3f_D20230414-20230414" name="dei:EntityAddressAddressLine1" id="f-7">2355 West Chandler Boulevard</ix:nonNumeric>, <ix:nonNumeric contextRef="i829a3695c8e54b839f595b7e5e02de3f_D20230414-20230414" name="dei:EntityAddressCityOrTown" id="f-8">Chandler</ix:nonNumeric>, <ix:nonNumeric contextRef="i829a3695c8e54b839f595b7e5e02de3f_D20230414-20230414" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-9">Arizona</ix:nonNumeric> <ix:nonNumeric contextRef="i829a3695c8e54b839f595b7e5e02de3f_D20230414-20230414" name="dei:EntityAddressPostalZipCode" id="f-10">85224-6199</ix:nonNumeric> </span></div><div style="margin-top:3pt;text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(Address of Principal Executive Offices, Including Zip Code)</span></div><div><span><br/></span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="i829a3695c8e54b839f595b7e5e02de3f_D20230414-20230414" name="dei:CityAreaCode" id="f-11">480</ix:nonNumeric>) <ix:nonNumeric contextRef="i829a3695c8e54b839f595b7e5e02de3f_D20230414-20230414" name="dei:LocalPhoneNumber" id="f-12">792-7200</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">(Registrant&#8217;s Telephone Number, Including Area Code)</span></div><div style="text-align:center"><span><br/></span></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</span></div><div style="padding-left:9pt;padding-right:9pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:0.1%"></td><td style="width:2.232%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:96.468%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i829a3695c8e54b839f595b7e5e02de3f_D20230414-20230414" name="dei:WrittenCommunications" format="ixt-sec:boolballotbox" id="f-13">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i829a3695c8e54b839f595b7e5e02de3f_D20230414-20230414" name="dei:SolicitingMaterial" format="ixt-sec:boolballotbox" id="f-14">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i829a3695c8e54b839f595b7e5e02de3f_D20230414-20230414" name="dei:PreCommencementTenderOffer" format="ixt-sec:boolballotbox" id="f-15">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:middle"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i829a3695c8e54b839f595b7e5e02de3f_D20230414-20230414" name="dei:PreCommencementIssuerTenderOffer" format="ixt-sec:boolballotbox" id="f-16">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</span></td></tr></table></div><div style="margin-top:5pt;padding-right:90pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-top:5pt;padding-left:51.75pt;padding-right:51.75pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Title of each class</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Trading Symbol(s)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%;text-decoration:underline">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i829a3695c8e54b839f595b7e5e02de3f_D20230414-20230414" name="dei:Security12bTitle" id="f-17">Common Stock, $0.001 par value per share</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i829a3695c8e54b839f595b7e5e02de3f_D20230414-20230414" name="dei:TradingSymbol" id="f-18">MCHP</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="i829a3695c8e54b839f595b7e5e02de3f_D20230414-20230414" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-19">NASDAQ Stock Market LLC</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;(Nasdaq Global Select Market)</span></td></tr></table></div><div style="padding-right:15.75pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.45 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div style="margin-bottom:5pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Emerging growth company</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="i829a3695c8e54b839f595b7e5e02de3f_D20230414-20230414" name="dei:EntityEmergingGrowthCompany" format="ixt-sec:boolballotbox" id="f-20">&#9744;</ix:nonNumeric></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> </span></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:9pt;font-weight:400;line-height:120%"> &#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:9pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="height:23.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="if97d4fd4815c408992fae0852e0bca4f_7"></div><hr style="page-break-after:always"/><div style="min-height:23.4pt;width:100%"><div><span><br/></span></div></div><div style="text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Item 8.01 Other Events</span></div><div style="text-align:justify"><span><br/></span></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">The Superior Court of the State of Arizona in and for the County of Maricopa has granted preliminary approval of the proposed settlement of shareholder derivative actions against certain current and former directors and officers of Microchip Technology Incorporated (&#8220;Microchip&#8221;), captioned </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Reid v. Sanghi</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, et al., Case No. CV2019-002389 and </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">Dutrisac v. Sanghi</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">, et al., Case No. CV2021-012459.  Microchip is named as a nominal defendant in the actions.  The actions allege various claims, including breach of fiduciary duty claims, relating to Microchip&#8217;s acquisition of Microsemi Corporation.  The actions were settled pursuant to a Stipulation of Settlement (the &#8220;Stipulation&#8221;), a copy of which is attached as Exhibit 99.1 to this Current Report on Form 8-K.</span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pursuant to the Court&#8217;s order granting preliminary approval of the settlement, Microchip is filing the Stipulation and Notice of Proposed Settlement of Stockholder Derivative Action (&#8220;Notice&#8221;) as an exhibit to this Form 8-K, publishing a summary of the Notice in Investor&#8217;s Business Daily and posting the Notice and Stipulation on its website at </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-style:italic;font-weight:400;line-height:120%">www.microchip.com/en-us/about/investors</span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">.  This website address is included for reference only.  The information contained on Microchip&#8217;s website is not incorporated by reference into this Form 8-K.</span></div><div><span><br/></span></div><div id="if97d4fd4815c408992fae0852e0bca4f_19"></div><div style="-sec-extract:summary;text-align:justify"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:174%">Item 9.01. Financial Statements and Exhibits.</span></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">(d) Exhibits. </span></div><div><span><br/></span></div><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">The following exhibits are filed herewith: </span></div><div><span><br/></span></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:524.25pt"><tr><td style="width:1.0pt"></td><td style="width:57.25pt"></td><td style="width:1.0pt"></td><td style="width:1.0pt"></td><td style="width:463.00pt"></td><td style="width:1.0pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Exhibit No.</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">Description</span></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr><td colspan="3" style="display:none"></td><td colspan="3" style="display:none"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">99.1</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%"><a style="-sec-extract:exhibit;color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%;text-decoration:none" href="exhibit991-noticeofpropose.htm">Notice of Proposed Stockholder Derivative Settlement and Stipulation of Settlement</a></span></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">104</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:112%">Cover Page Interactive Data File (embedded within the Inline XBRL document)</span></td></tr></table></div><div><span><br/></span></div><div style="height:23.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="if97d4fd4815c408992fae0852e0bca4f_22"></div><hr style="page-break-after:always"/><div style="min-height:23.44pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:8pt;text-align:center"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div><span><br/></span></div><div style="padding-left:4.5pt;padding-right:4.5pt;text-indent:36pt"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div><span><br/></span></div><div style="margin-top:10pt;text-align:center;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.852%"><tr><td style="width:1.0%"></td><td style="width:50.007%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:47.793%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:700;line-height:100%">MICROCHIP TECHNOLOGY INCORPORATED</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Date:  April 14, 2023</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">By:   </span><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%;text-decoration:underline">/s/ J. Eric Bjornholt                                </span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">J. Eric Bjornholt</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">Senior Vice President and Chief Financial Officer</span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">&#160;</span></td><td colspan="3" style="padding:2px 1pt 2px 25.75pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">(Principal Financial and Accounting Officer)</span></td></tr></table></div><div style="height:23.4pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>exhibit991-noticeofpropose.htm
<DESCRIPTION>EX-99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd"><html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i543c4edc48754904831da53a767507a1_4"></div><div style="min-height:49.68pt;width:100%"><div><font><br></font></div></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:12pt;font-weight:700;line-height:100%">EXHIBIT 99.1</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MCKAY LAW</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MICHAEL C. MCKAY (SBN 023354)</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7702 East Double Tree Ranch Road</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Suite 300 </font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Scottsdale, AZ 85258</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Telephone&#58; (480) 681-7000</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Facsimile&#58; (480) 348-3999</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ROBBINS LLP</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BRIAN J. ROBBINS</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">STEPHEN J. ODDO </font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ERIC M. CARRINO</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5060 Shoreham Place, Suite 300</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">San Diego, CA 92122<br>Telephone&#58; (619) 525-3990<br>Facsimile&#58; (619) 525-3991</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">E-mail&#58; brobbins&#64;robbinsllp.com</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; soddo&#64;robbinsllp.com</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; ecarrino&#64;robbinsllp.com</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Attorneys for Plaintiff Michael Reid</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;Additional Counsel on signature page&#93;</font></div><div><font><br></font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">IN THE SUPERIOR COURT OF THE STATE OF ARIZONA</font></div><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">IN AND FOR THE COUNTY OF MARICOPA</font></div><div style="text-align:center"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.261%"><tr><td style="width:1.0%"></td><td style="width:51.158%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.642%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MICHAEL REID, Derivatively on Behalf of MICROCHIP TECHNOLOGY, INC.,</font></div><div><font><br></font></div><div style="padding-left:144pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plaintiff,</font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">v.</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">STEVE SANGHI, GANESH MOORTHY, J. ERIC BJORNHOLT, L.B. DAY, MATTHEW W. CHAPMAN, WADE F. MEYERCORD, AND ESTHER L. JOHNSON,</font></div><div><font><br></font></div><div style="padding-left:144pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defendants, </font></div><div style="padding-left:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-and-</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MICROCHIP TECHNOLOGY, INC., a Delaware corporation,</font></div><div><font><br></font></div><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nominal Defendant.</font></div></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Case No. CV2019-002389</font></div><div style="padding-left:4.5pt"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">STIPULATION OF SETTLEMENT</font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="padding-left:4.5pt"><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Assigned to The Honorable Timothy Thomason)</font></div></td></tr></table></div><div style="margin-top:12pt;padding-right:-2.9pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;Caption continued on next page&#93;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:92.857%"><tr><td style="width:1.0%"></td><td style="width:50.823%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:46.977%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RICHARD DUTRISAC, derivatively on behalf of MICROCHIP TECHNOLOGY INCORPORATED,</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Plaintiff,</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">v.</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">STEVE SANGHI, GANESH MOORTHY, JAMES ERIC BJORNHOLT, MATTHEW&#160;W. CHAPMAN, WADE F. MEYERCORD, ESTHER&#160;L. JOHNSON, L.B. DAY, and KAREN RAPP,</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Defendants,</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">and</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MICROCHIP TECHNOLOGY INCORPORATED, a Delaware corporation,</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Nominal Defendant.</font></div></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Case No. CV2021-012459</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="i543c4edc48754904831da53a767507a1_7"></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Stipulation of Settlement (&#34;Stipulation&#34; or &#34;Settlement&#34;) is made and entered into by and among plaintiffs Michael Reid (&#34;Reid&#34;) and Richard Dutrisac (&#34;Dutrisac&#34;) (collectively, &#34;Plaintiffs&#34;), on behalf of themselves and derivatively on behalf of Microchip Technology Incorporated (&#34;Microchip&#34; or the &#34;Company&#34;), counsel for plaintiffs Robbins LLP (&#34;Robbins&#34;), McKay Law (&#34;McKay&#34;), Johnson Fistel, LLP (&#34;Johnson Fistel&#34;), and Dessaules Law Group (&#34;Dessaules&#34;), defendants Steve Sanghi, Ganesh Moorthy, J. Eric Bjornholt, L.B. Day, Matthew W. Chapman, Wade F. Meyercord, Esther L. Johnson, and Karen Rapp (together, the &#34;Individual Defendants&#34; or &#34;Settling Defendants&#34;), nominal defendant Microchip (together with Plaintiffs and the Settling Defendants, the &#34;Settling Parties&#34;), and counsel for the Individual Defendants and Microchip, Osborn Maledon, P.A. and Wilson Sonsini Goodrich &#38; Rosati, P.C.  The Stipulation is intended by the Settling Parties to fully, finally, and forever resolve, discharge, and settle the Released Claims (as defined below in Section IV, &#182;A.11) upon Court approval and subject to the terms and conditions hereof.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">I.&#160;&#160;&#160;&#160;BACKGROUND</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">&#160;&#160;&#160;&#160;Reid </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Action</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 22, 2019, plaintiff Reid filed an action captioned, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reid v. Sanghi, et al.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Case No. CV2019-002389, in the Superior Court of Arizona for Maricopa County (the &#34;Arizona Superior Court&#34; or the &#34;Court&#34;) against the Individual Defendants and the Company as nominal defendant (the &#34;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reid</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Action&#34;).  </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plaintiff Reid alleges that the Individual Defendants breached their fiduciary duties to Microchip and its stockholders by issuing a series of allegedly materially false and misleading statements regarding the operations and financial performance of Microsemi Corporation (&#34;Microsemi&#34;), a computer chip manufacturer it acquired for $10.15 billion.  The </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reid </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Action also brings a claim against the Individual Defendants for waste of corporate assets and unjust enrichment.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Settling Defendants deny each and every one of the claims and contentions alleged by Plaintiff Reid.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">B.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dutrisac</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Action </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 5, 2021, plaintiff Dutrisac filed suit on behalf of Microchip in this Court alleging his demand served on the Board on April 13, 2020 was wrongfully refused by the Microchip Board (the &#34;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dutrisac </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Action&#34; and together with the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reid </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Action, the &#34;Actions&#34;).  The </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dutrisac</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Action also alleges that the named Individual Defendants breached their fiduciary duties to Microchip and its stockholders by issuing allegedly materially false and misleading statements related to the Company&#8217;s acquisition of Microsemi, and as to certain of the Individual Defendants, by trading on material, adverse information related to the Company&#8217;s business.  The </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dutrisac</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Action brings claims against the named Individual Defendants for breach of fiduciary duties, insider selling, corporate waste, unjust enrichment, and contribution and indemnification.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Settling Defendants deny each and every one of the claims and contentions alleged by Plaintiff Dutrisac therein.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">C.&#160;&#160;&#160;&#160;Denial of Motions to Dismiss</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;On March 12, 2021, members of the Audit Committee of Microchip&#8217;s Board of Directors moved to dismiss the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reid </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Action.  After full briefing and oral argument, the Court denied the motion to dismiss on April 1, 2022.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;On January 28, 2022, members of the Audit Committee of Microchip&#8217;s Board of Directors moved to dismiss the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dutrisac</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Action.  After full briefing and oral argument, the Court denied the motion to dismiss on April 7, 2022.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">D.&#160;&#160;&#160;&#160;Partial Consolidation of the Stockholder Derivative Actions in the Arizona Superior Court</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 10, 2023, the Arizona Superior Court entered an Order Granting Joint Stipulation Regarding Partial Consolidation of Derivative Actions.  The Court's Order consolidated the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reid </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dutrisac </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actions for the limited purpose of pretrial discovery matters.  The Order further provided that &#34;&#91;d&#93;iscovery shall proceed according to this Court's prior scheduling orders entered in the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reid</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dutrisac</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Actions, and, absent stipulation by the parties or further order by the Court, plaintiffs Michael Reid and Richard Dutrisac (&#8216;Plaintiffs&#8217;) shall coordinate discovery and be subject to all discovery limitations therein and all disclosure rights and obligations thereunder as if Plaintiffs were a single party.&#34;  The Settling Defendants produced more than 900,000 pages of documents to Plaintiffs' Counsel and the Settling Parties had begun setting deposition dates.  </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">E.&#160;&#160;&#160;&#160;The Mediation</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Settling Parties actively engaged in continued discussions aimed at potential resolution of the Actions.  Specifically, the Settling Parties submitted extensive mediation statements to Robert A. Meyer, Esq. (&#8220;Mr. Meyer&#8221; or the &#8220;Mediator&#8221;) and met for a full-day videoconference mediation session before Mr. Meyer, on August 24, 2022.  As a result of the mediation and subsequent arm's-length settlement negotiations overseen by the Mediator that followed, the Settling Parties reached an agreement that, subject to approval of the Court, resolves the Actions and the Released Claims as further described herein.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">F.&#160;&#160;&#160;&#160;The Microchip Board of Directors' Approval of the Settlement</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The members of Microchip's Board of Directors unanimously approved the Settlement on February 21, 2023 and unanimously determined that the Settlement is in the best interests of Microchip and its stockholders.  The Settling Defendants acknowledge that the Settlement detailed herein  confers substantial benefits for the Company and its stockholders and that the benefits of the Settlement, including the corporate governance enhancements and the $4,000,000 monetary payment to be made by the Company&#8217;s insurer(s) to the Company, were caused by Plaintiffs and their counsel&#8217;s commencement and prosecution of the Actions.</font></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">- 1 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">II.&#160;&#160;&#160;&#160;PLAINTIFFS' CLAIMS AND BENEFITS OF SETTLEMENT</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plaintiffs and Plaintiffs' Counsel believe that the claims asserted in the Actions have merit.  Plaintiffs and Plaintiffs' Counsel recognize and acknowledge the expense and length of continued proceedings necessary to prosecute the Actions against the Settling Defendants through motion practice, trial, and potential appeals.  Plaintiffs and Plaintiffs' Counsel also have taken into account the uncertain outcome and the risk of any litigation, especially in complex actions such as the Actions, as well as the difficulties and delays inherent in such litigation.  Plaintiffs and Plaintiffs' Counsel also are mindful of the inherent problems of proof of, and possible defenses to, the claims asserted in the Actions.  Based on their evaluation, Plaintiffs and Plaintiffs' Counsel have determined that the Settlement set forth in this Stipulation is in the best interests of Microchip and its stockholders.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">III.&#160;&#160;&#160;&#160;THE SETTLING DEFENDANTS' DENIALS OF WRONGDOING AND LIABILITY</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Settling Defendants deny each and every one of the claims and contentions alleged by Plaintiffs.  The Settling Defendants expressly deny all allegations of wrongdoing or liability against them, or any of them, or any other current or former Microchip directors or officers, arising out of, based upon, or related to any of the conduct, statements, acts, or omissions alleged, or that could have been alleged, in the Actions.  Without limiting the foregoing, the Settling Defendants deny, among other things, that they or any other current or former Microchip directors or officers breached their fiduciary duties, or any other duty owed to Microchip or its stockholders, or engaged in any wrongdoing whatsoever.  The Settling Defendants further deny that Plaintiffs, Microchip, or Microchip's stockholders suffered any damage or were harmed as a result of any conduct alleged in the Actions or otherwise.  The Settling Defendants have further asserted and continue to assert that at all relevant times, they and all other current or former Microchip directors or officers acted in good faith and in a manner they reasonably believed to be in the best interests of Microchip and its stockholders.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nonetheless, the Settling Defendants also have taken into account the expense, uncertainty, and risks inherent in any litigation, especially in complex cases like the Actions.  The Settling Defendants are entering into this Stipulation solely because the proposed Settlement would eliminate the burden and expense of further litigation, and without admitting any wrongdoing or liability whatsoever.  </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Therefore, the Settling Defendants have determined that it is desirable and beneficial that the Actions, and all of the Settling Parties' disputes related thereto, be fully and finally settled in the manner and upon the terms and conditions set forth in this Stipulation.  Pursuant to the terms set forth below, this Stipulation, including all of the commitments and undertakings agreed to by the Settling Defendants, and all attached Exhibits hereto, shall in no event be construed as or deemed to be evidence of an admission or concession by the Settling Defendants with respect to any claim of fault, liability, wrongdoing, or damage whatsoever.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IV.&#160;&#160;&#160;&#160;TERMS OF STIPULATION AND AGREEMENT OF SETTLEMENT</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">NOW, THEREFORE, IT IS HEREBY STIPULATED AND AGREED by and among Plaintiffs (for themselves and derivatively on behalf of Microchip), by and through Plaintiffs' Counsel, and the Settling Defendants and Microchip, by and through their attorneys of record, that in exchange for the consideration set forth below, the Actions and Released Claims shall be fully, finally, and forever compromised, settled, discharged, relinquished, and released, and the Actions shall be dismissed with prejudice as to the Settling Defendants, upon and subject to the terms and conditions of this Stipulation, as follows&#58;</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A.&#160;&#160;&#160;&#160;Definitions</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As used in this Stipulation the following terms have the meanings specified below&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;&#34;Actions&#34; means the futility action filed by plaintiff Reid on January 22, 2019, and captioned </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reid v. Sanghi, et al.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Case No. CV2019-002389, pending in the Arizona Superior Court (&#34;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reid</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Action&#34;), and the demand refused action filed by plaintiff Dutrisac on August 5, 2021, and captioned </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dutrisac v. Sanghi</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Case No. CV2021-012459, pending in the Arizona Superior Court (&#34;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dutrisac</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Action&#34;).</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;&#34;Court&#34; or &#34;Arizona Superior Court&#34; means the Superior Court of the State of Arizona in and for the County of Maricopa.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;&#34;Effective Date&#34; means the first date by which all of the events and conditions specified in Section IV, &#182;G of this Stipulation have been met and have occurred.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;&#34;Final&#34; means the time when the Judgment has not been reversed, vacated, or modified in any way and is no longer subject to appellate review, either because of disposition on appeal and conclusion of the appellate process or because of passage, without action, of time for seeking appellate review.  More specifically, it is that situation when&#58; (1) either no appeal has been filed and the time has passed for any notice of appeal to be timely filed in the Actions&#59; or (2) an appeal has been filed and the court(s) of appeal has&#47;have either affirmed the Judgment or dismissed that appeal and the time for any reconsideration or further appellate review has passed and the appellate court mandate(s) has&#47;have issued&#59; or (3) a higher court has granted further appellate review and that court has either affirmed the underlying Judgment or affirmed the court of appeal's decision affirming the Judgment or dismissing the appeal.</font></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">- 2 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;&#34;Final Order and Judgment&#34; or &#8220;Judgment&#8221; means the judgment to be rendered by the Court in the Actions upon its final approval of the Settlement, substantially in the form attached as Exhibit B hereto.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.&#160;&#160;&#160;&#160;&#34;Plaintiffs' Counsel&#34; means the law firms of Robbins, McKay, Johnson Fistel, and Dessaules.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.&#160;&#160;&#160;&#160;''Plaintiffs&#34; means plaintiffs Michael Reid and Richard Dutrisac.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.&#160;&#160;&#160;&#160;&#34;Microchip&#34; or the &#34;Company&#34; means Microchip Technology Incorporated, including, but not limited to, its predecessors, successors, partners, joint ventures, subsidiaries, affiliates, divisions, and assigns.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.&#160;&#160;&#160;&#160;&#34;Person&#34; means an individual, corporation, limited liability company, professional corporation, limited liability partnership, partnership, limited partnership, association, joint venture, joint stock company, estate, legal representative, trust, unincorporated association, government or any political subdivision or agency thereof, and any business or legal entity, and each of their spouses, heirs, predecessors, successors, representatives, or assignees.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.&#160;&#160;&#160;&#160;&#34;Related Parties&#34; means (i)</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">as to Microchip, Microchip's past or present directors, officers, managers, employees, partners, agents, attorneys, accountants, auditors, banks, insurers, co-insurers, re-insurers, advisors, consultants, experts, successors, subsidiaries, divisions, joint ventures, assigns, general or limited partners or partnerships, limited liability companies, any entity in</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">which Microchip has a controlling interest, and all officers, directors and employees of Microchip's current and former subsidiaries&#59; and (ii) as to the Settling Defendants, (1) each spouse, immediate family member, heir, executor, estate, administrator, agent, attorney, accountant, auditor, bank, insurer, co-insurer, re-insurer, advisor, consultant, expert, or affiliate of any of them, (2) any trust in respect of which any Settling Defendant, or any spouse or family member thereof serves as a settlor, beneficiary, or trustee, and (3) any entity in which a Settling Defendant, or any spouse or immediate family member thereof, holds a controlling interest or for which a Settling Defendant has served as an employee, director, officer, managing director, advisor, general partner, limited partner, or member and any collective investment vehicle which is advised or managed by any of them.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.&#160;&#160;&#160;&#160;&#34;Released Claims&#34; means all claims, demands, rights, liabilities, and claims for relief of every nature and description whatsoever, known or unknown (as set forth in Section IV, &#182;A.17), that have been, or could have been, asserted in the Actions by Plaintiffs, Microchip, or any Microchip stockholder derivatively on behalf of Microchip against the Settling Defendants and Released Persons arising out of, or relating to, any of the facts, transactions, events, matters, occurrences, acts, disclosures, statements, alleged omissions, or alleged failures to act in connection with or related to the acquisition of Microsemi.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.&#160;&#160;&#160;&#160;&#34;Released Persons&#34; means the Settling Defendants, Microchip, and their respective Related Parties.  As defined in Section IV, &#182;A.10 above, Related Parties includes, but is not limited to, all current and former Microchip directors and officers, including all those who are named as defendants in the stockholder derivative actions described in Section I, above.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.&#160;&#160;&#160;&#160;&#34;Settlement&#34; means the terms and conditions contained in this Stipulation.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.&#160;&#160;&#160;&#160;&#34;Settling Defendants&#34; means Steve Sanghi, Ganesh Moorthy, J. Eric Bjornholt, L.B. Day, Matthew W. Chapman, Wade F. Meyercord, Esther L. Johnson, and Karen Rapp.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.&#160;&#160;&#160;&#160;&#34;Settling Parties&#34; means, collectively, Plaintiffs, the Settling Defendants, and Microchip.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.&#160;&#160;&#160;&#160;&#34;Stipulation&#34; means this Stipulation of Settlement.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17.&#160;&#160;&#160;&#160;&#34;Unknown Claims&#34; means any actions, suits, claims, demands, rights, liabilities, and causes of action, including both known claims and Unknown Claims (as defined herein), which Plaintiffs, Microchip, or a Microchip stockholder does not know or suspect to exist in his, her, or its favor at the time of the release of the Released Persons, including claims which, if known by him, her, or it, might have affected his, her, or its settlement with, and release of the Released Persons, or might have affected his, her, or its decision not to object to this Settlement.  With respect to any and all Released Claims, the Settling Parties stipulate and agree that, upon the Effective Date, Plaintiffs, Microchip, and its stockholders shall be deemed to have, and by operation of the Judgment shall have, expressly waived, the provisions, rights, and benefits of California Civil Code &#167;1542, and by any law of any state or territory of the United States or any other state, sovereign, or jurisdiction, or any principle of common law that is similar, comparable, or equivalent to Section 1542 of the California Civil Code, which provides&#58;</font></div><div style="padding-left:36pt;padding-right:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A GENERAL RELEASE DOES NOT EXTEND TO CLAIMS WHICH THE CREDITOR DOES NOT KNOW OR SUSPECT TO EXIST IN HIS OR HER FAVOR AT THE TIME OF EXECUTING THE RELEASE, WHICH IF KNOWN BY HIM OR HER MUST HAVE MATERIALLY AFFECTED HIS OR HER SETTLEMENT WITH THE DEBTOR.</font></div><div style="text-align:justify"><font><br></font></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">- 3 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Further, with respect to any and all claims released pursuant to Section IV.D, below, the Settling Parties stipulate and agree that, upon the Effective Date, each of the Released Persons also shall expressly waive, and by operation of the Judgment shall have expressly waived any and all provisions, rights, and benefits conferred by any law of any jurisdiction or any state or territory of the United States, or principle of common law, which is similar, comparable, or equivalent to California Civil Code &#167;1542.  Plaintiffs, Microchip, and each Microchip stockholder may hereafter discover facts in addition or different from those which he, she, or it now knows or believes to be true with respect to the subject matter of the Released Claims, known or unknown, suspected or unsuspected, contingent or non-contingent, whether or not concealed or hidden, which now exist, or heretofore have existed upon any theory of law or equity now existing or coming into existence in the future, including, but not limited to, conduct which is negligent, intentional, with or without malice, or a breach of any duty, law, or rule, without regard to the subsequent discovery or existence of such different or additional facts.  The Settling Parties acknowledge, and the Microchip stockholders shall be deemed by operation of the Judgment to have acknowledged, that the foregoing waiver was separately bargained for and is a key element of the Settlement of which this release is a part.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">B.&#160;&#160;&#160;&#160;Consolidation</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">For purposes of effectuating the Settlement, the parties agree and hereby stipulate to the consolidation of the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reid</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dutrisac</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> actions.</font></div><div style="padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">C.&#160;&#160;&#160;&#160;Consideration</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;In connection of the settlement of the Actions, Defendants through their insurer will pay the total amount of $4 million (the &#34;Settlement Amount&#34;) into an interest-bearing escrow account to be established by Plaintiffs' Counsel.  The Settlement Amount shall be paid into the escrow account within twenty (20) business days after the later of&#58; (a) the date of entry when the Court enters the Preliminary Approval Order as defined below&#59; or (b) Defendants&#8217; counsel&#8217;s receipt from Plaintiffs&#8217; Counsel of the information necessary to effectuate a transfer of funds to the escrow account, including wiring instructions that include the bank name and ABA routing number, account name and number, and a signed W-9 reflecting a valid taxpayer identification number.  </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;Within five (5) business days of the entry of the Final Order and Judgment, Plaintiffs' Counsel shall cause the Settlement Amount and any and all interest earned thereon, less the attorneys&#8217; fees and expense awarded by the Court from the Settlement Amount, and Plaintiffs' service awards, to be paid from the escrow account to Microchip.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Also, in connection with the settlement of the Actions, the Microchip Board of Directors has approved the implementation of the corporate governance measures detailed below.  Microchip shall implement the corporate governance measures specified herein within sixty (60) days following final judicial approval of the proposed Settlement by the Court.  Microchip acknowledges and agrees that the corporate governance enhancements set forth below confer substantial benefits upon Microchip and its stockholders.  Microchip acknowledges that the commencement and prosecution of the Actions and negotiations of the Settlement with Plaintiffs' Counsel were the cause of the Company&#8217;s decision to implement and enhance its corporate governance measures and internal controls programs.  Except as otherwise specified, the corporate governance enhancements and internal controls programs described below shall remain in effect for five (5) years from the date of adoption.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Enhancement of Management-Level Disclosure Committee</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;Function</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Company shall maintain its management-level Disclosure Committee (&#34;Disclosure Committee&#34;) and adopt a charter for the Disclosure Committee. The Disclosure Committee will review its charter annually. Any changes to the Disclosure Committee's charter must be approved by the Certifying Officers (defined below).</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The function of the Disclosure Committee will be to review certain public disclosures made by the Company in its U.S. Securities and Exchange Commission (&#34;SEC&#34;) filings.  The Committee will review the disclosures with respect to whether they&#58;  (i) are accurate, complete, and timely&#59; (ii) fairly present the Company's financial condition, results of operations and cash flows in material respects&#59; and (iii) meet any other applicable laws and stock exchange requirements that are brought to the attention of the Committee. The Disclosure Committee shall hold regular meetings prior to each Form 10-K and Form 10-Q filing required by the Securities Exchange Act of 1934.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;Composition</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Disclosure Committee members shall consist of the Company's Chief Executive Officer (&#34;CEO&#34;), Chief Financial Officer (&#34;CFO&#34;), and the Chief Compliance Officer (&#34;CCO&#34;) (described infra), and other representatives of the Company. Additional committee members may be appointed and&#47;or removed by the CEO and&#47;or CFO (the &#34;Certifying Officers&#34;) at any time.  One member of the Disclosure Committee will be designated the Committee's Chairperson by the Certifying Officers.  The Chairperson shall schedule and preside over meetings.  Any interpretation of the charter or the Disclosure Committee's procedures shall be made by the Disclosure Committee Chairperson.  The Chairperson or the Certifying Officers may retain outside consultants or advisors as appropriate.  The Chairperson will report quarterly to the Audit Committee of the Board.  The Company shall also finalize a formal written charter for the Disclosure Committee, which has been reviewed by Plaintiffs&#8217; Counsel prior to the execution of this Stipulation.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Duties and Responsibilities</font></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">- 4 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Disclosure Committee shall&#58;</font></div><div style="text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;Establish and maintain policies and procedures designed to ensure that information required to be disclosed by the Company in its filings with the SEC and other information that the Company discloses to the public is recorded, processed, summarized, and reported accurately and timely, including policies and procedures for evaluating periodic disclosures, as well as procedures and policies for periodically assessing the effectiveness of the Company's disclosure controls&#59;</font></div><div style="text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;Participate in the evaluation of the effectiveness of the Company's disclosure controls annually&#59;</font></div><div style="text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;Review drafts of the Company's Form 10-Q and Form 10-K and approve as to form and content materially final versions of the Company's Form 10-Q and Form 10-K filings&#59; </font></div><div style="text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)&#160;&#160;&#160;&#160;Provide updates to the Audit Committee, as appropriate, concerning disclosure and related risk factor issues identified by the Disclosure Committee&#59; and </font></div><div style="text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(v)&#160;&#160;&#160;&#160;Provide updates to the Board, as appropriate, to ensure that the Board has sufficient information relevant to the Disclosure Committee's work such that the Board can appropriately discharge its obligations. </font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;In order to execute its responsibilities, the Disclosure Committee shall have full access to all Company books, records, facilities and employees, including independent auditors.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Acquisition Oversight Reforms  </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;In connection with any mergers and acquisitions that are material to the Company (&#34;Acquisition&#34; -- which for purpose of this Section C shall mean that the acquisition is of a publicly traded company of any size or a private company with a purchase price equal to or greater than 5% of the Company's market capitalization at the time the definitive agreement is signed), management shall do the following&#58;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Present to the Board concerning acquisition priorities for due diligence that address lessons learned from prior acquisitions&#59;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Present to the Board concerning management's analysis of the potential benefits and risks of material acquisitions&#59;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Present to the Board management's analysis and recommendations regarding such acquisition&#59; and</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Following any material acquisition of another company, conduct a &#34;lessons learned&#34; session with the Board and provide periodic updates concerning the status of integration efforts.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;The Company shall adhere to the following policies concerning a potential or actual Acquisition&#58; </font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Insider Trading Compliance Officer shall consult with external counsel with respect to stock trading windows in or around Acquisitions, including during the period from any offering being made through closing.  </font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;For the first quarterly period ending after the closing of an Acquisition, the Company shall disclose the revenue and profit from the business that was acquired.        </font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Enhancements to the Duties and Responsibilities of the Audit Committee</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;The Board shall adopt an updated charter of the Audit Committee that includes provisions, or shall otherwise provide, that&#58;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Audit Committee shall be responsible for evaluating disciplinary recommendations for violations of codes of conduct by executive officers and directors, and, together with the Company's independent directors (excepting any independent director who may be the subject of disciplinary review), making final determinations regarding such discipline&#59; </font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The Company shall have a policy that&#58; </font></div><div style="text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;prohibits executive officers from interfering with or exercising undue influence on any member of the Audit Committee concerning any discoveries or conclusions of any Audit Committee investigation&#59; </font></div><div style="text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;prohibits Company executive officers from requesting information from members of the Audit Committee concerning an Audit Committee's investigation, discoveries, or conclusions&#59; and</font></div><div style="text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;requires that all Company executives cooperate with Audit Committee investigations, and that any failure to cooperate may be grounds for discipline by the Board, including, but not limited to, termination, in the sole discretion of the Board&#59;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;The Audit Committee shall receive a report from the Company's management and the Company's independent auditors regarding the financial statements included in the Company's Form 10-K and Form 10-Q&#59; and</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;The Audit Committee shall receive quarterly reports from the Company's CCO.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Appointment of Chief Compliance Officer</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;Microchip shall appoint a CCO (who need not be an executive officer).  The CCO shall work with senior management (including the General Counsel) on matters of corporate compliance, ethics, and governance.  The CCO shall assume primary responsibility for oversight and administration of the Company's corporate governance policies (including the Code of Business Conduct and Ethics, and Corporate Governance Guidelines), coordinating with other senior executives in fostering a culture that integrates compliance and ethics into business processes and practices, and maintaining and </font></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">- 5 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">monitoring a system for reporting and investigating potential compliance and ethics concerns.  The CCO will assist the Audit Committee and the Board in fulfilling their oversight duties with respect to the Company's compliance with applicable laws and regulations.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;The CCO's responsibilities shall include&#58;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Managing and overseeing the Company's Corporate Governance Guidelines&#59;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Serving on the Company's Disclosure Committee&#59;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Retaining independent third-party advisors as appropriate&#59;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Working with the Company's General Counsel to evaluate the adequacy of the Company's legal and regulatory compliance&#59; and</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;Overseeing executive training in risk assessment, compliance, and public and internal communications, and facilitating and overseeing the training of new Board members.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Director Term Limits</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;No non-employee director shall serve as a member of the Board for a period of time exceeding seventeen (17) years.  This term shall be implemented within one (1) year from the date such terms are agreed to and shall be maintained for no less than twenty (20) years.  This term shall apply to all non-employee directors on the Board as of the Effective Date&#59; however, it will not be retroactively applied (i.e., for current directors, years served before the implementation of this requirement do not count toward the 17 years.)</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Lead Independent Director</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;In the event the Chair of the Board is not an &#34;independent director&#34;, the Board shall appoint a Lead Independent Director who satisfies such independence.  The Lead Independent Director may receive such additional compensation for his or her services as the Board of the Company may determine.  The Lead Independent Director shall have the following responsibilities&#58;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;To review Board meeting agendas in advance of each meeting and Board meeting schedules to ensure sufficient time for discussion of agenda items&#59;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;To consult and collaborate with the non-independent Chair as appropriate&#59;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Chair any executive sessions of the Board which occur outside the presence of the non-independent Chair, the CEO and any other members of management then serving on the Board&#59;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;To call meetings of independent directors at any time he or she deems appropriate&#59;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;To chair Board meetings when the non-independent Chair is not present&#59; </font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;To retain outside advisors in connection with the performance of these duties as he or she deems appropriate&#59; and </font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;To perform such other duties as the Board may deem appropriate from time to time.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Enhanced Director Independence</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;The Board shall revise the Company's Bylaws and Corporate Governance Guidelines to require three-fourths of the directors (rounded down) of the Board be &#34;independent&#34; as defined by the Nasdaq Stock Market, Inc. (e.g., for a seven-person board, five directors must be independent).</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;If the Company fails to comply with the independence requirements set forth herein due to one or more vacancies of the Board, or if one or more directors cease to be independent due to circumstances beyond their reasonable control, Microchip shall within 180 days regain compliance with these requirements.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Board Self Evaluation</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;The Company's Corporate Governance Guidelines shall be revised to provide for mandatory evaluation of the effectiveness of the Board's governance and oversight procedures in a process designed and approved by the Nominating, Governance and Sustainability Committee, which shall consider NACD or other sources of guidance regarding governance best practices.  The evaluation process shall address the adequacy and timeliness of information and advisory resources made available to Board members&#59; the adequacy of time provided to members for fact-finding, consultations with management, and deliberations&#59; and the Chairperson's effectiveness, among other matters.  The Nominating, Governance and Sustainability Committee will review the results and prepare recommendations for improvements to the whole Board and any relevant committees.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">D.&#160;&#160;&#160;&#160;Settlement Procedures</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;After execution of this Stipulation, Plaintiffs shall promptly submit the Stipulation together with its Exhibits to the Court and shall move for entry of an order substantially in the form of Exhibit A hereto (the &#34;Preliminary Approval Order&#34;), requesting, among other things, the preliminary approval of the Settlement set forth in the Stipulation, and approval for the filing and publication of the Settlement Notice, substantially in the forms attached hereto as Exhibits A-1 (&#34;Long-Form Notice&#34;) and A-2 (&#34;Short-Form Notice&#34;&#59; the Long-Form Notice and Short Form Notice collectively, the &#34;Settlement Notice&#34;), which shall include the general terms of the Settlement set forth in the Stipulation and the date of the Settlement Hearing as described below.</font></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">- 6 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;Within seven (7) business days following the Court's entry of the Preliminary Approval Order, Microchip shall cause the Stipulation and Long-Form Notice to be filed with the U.S. Securities and Exchange Commission (&#34;SEC&#34;) along with an SEC Form 8-K or other appropriate filing, and publish the Short-Form Notice one time in </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Investor's Business Daily.  </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The SEC filing will be accessible via a link on the &#8220;Investor Relations&#8221; page of https&#58;&#47;&#47;www.Microchip.com, the address of which shall be contained in the Settlement Notice.  Microchip shall bear all costs associated with this Settlement Notice, or any other form or manner of notice approved and&#47;or required by the Court.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Plaintiffs will also request that no less than forty-five (45) days after the Settlement Notice is given, the Court hold a hearing in the Actions (the &#34;Settlement Hearing&#34;) to consider and determine whether the Final Order and Judgment, substantially in the form of Exhibit B hereto, should be entered&#58; (a) approving the terms of the Settlement as fair, reasonable, and adequate&#59; and (b) dismissing with prejudice the Actions against the Settling Defendants.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;Pending the Effective Date, all proceedings and discovery in the Actions shall be stayed except as otherwise provided herein, and the Settling Parties shall not file or prosecute any other actions or proceedings relating to the Settlement.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">E.&#160;&#160;&#160;&#160;Releases</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;Upon the Effective Date, as defined in Section IV, &#182;A.3, Microchip, Microchip stockholders, or any Person acting on behalf of Microchip and Plaintiffs (acting on their own behalf and&#47;or derivatively on behalf of Microchip) shall be deemed to have, and by operation of the Judgment shall have, fully, finally, and forever released, relinquished, and discharged and dismissed with prejudice the Released Claims against the Released Persons and any and all causes of action or claims (including Unknown Claims) that have or could have been asserted in the Actions by Plaintiffs, Microchip, or any Microchip stockholder derivatively on behalf of Microchip, or Microchip against the Settling Defendants or the Released Persons arising out of, or relating to, the facts, transactions, events, matters, occurrences, acts, disclosures, statements, alleged omissions, or alleged failures to act related to the acquisition of Microsemi.  Nothing herein shall in any way impair or restrict the rights of any Settling Party or any other Released Person to enforce the terms of the Stipulation.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;Upon the Effective Date, as defined in Section IV, &#182;A.3, Microchip, Microchip stockholders, or any Person acting on behalf of Microchip, and Plaintiffs (acting on his own behalf and derivatively on behalf of Microchip and its stockholders) shall be forever barred and enjoined from commencing, instituting, or prosecuting any of the Released Claims against any of the Released Persons or any action or other proceeding against any of the Released Persons arising out of, relating to, or in connection with the Released Claims, the Actions, or the filing, prosecution, defense, settlement, or resolution of the Actions.  Nothing herein shall in any way impair or restrict the rights of any Settling Party to enforce the terms of the Stipulation.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Upon the Effective Date, as defined in Section IV, &#182;A.3, each of the Released Persons and the Related Parties shall be deemed to have, and by operation of the Judgment shall have, fully, finally, and forever released, relinquished, and discharged Plaintiffs, Plaintiffs' Counsel, and all current Microchip stockholders (solely in their capacity as Microchip stockholders) from all claims (including Unknown Claims) arising out of, relating to, or in connection with the institution, prosecution, assertion, settlement, or resolution of the Actions or the Released Claims. Nothing herein shall in any way impair or restrict the rights of any Settling Party to enforce the terms of the Stipulation.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">F.&#160;&#160;&#160;&#160;Plaintiffs' Counsel's Separately Negotiated Attorneys' Fees and Expenses</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;After negotiating and agreeing upon the principal terms of the Settlement, Plaintiffs' Counsel and Microchip, acting by and through its counsel, with the assistance of the Mediator, separately negotiated the attorneys' fees and expenses the Company would pay to Plaintiffs' Counsel.  In light of the substantial benefits conferred by Plaintiffs' Counsel's efforts, Microchip, acting by and through its Board of Directors, has agreed not to oppose a fee and expense award of $3 million, consisting of (i) 30 percent of the $4 million Settlement Amount, or $1.2 million, subject to Court approval&#59; and (ii) $1.8 million from Microchip, in connection with the corporate governance measures, which the Company agrees to pay subject to Court approval (the &#34;Fee and Expense Amount&#34;).</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;Within ten (10) calendar days following the Court's issuance of the Judgment, notwithstanding the existence of any timely filed objections to the Settlement, or potential for appeal therefrom, Microchip shall make payment of $1.8 million in connection with the corporate governance measures, subject to Court approval, to an account controlled by Plaintiffs' Counsel.  Additionally, Plaintiffs' Counsel shall withdraw the fee amount awarded by the Court from the Settlement Amount, which in any event shall not exceed $1.2 million, from the Settlement Amount.  If, as a result of any further order of the Court or as a result of any appeal, remand, or successful collateral attack, the Effective Date does not occur or if the Fee and Expense Amount is not approved or is modified or overturned, in whole or in part, then Plaintiffs' Counsel shall be responsible for repayment to Microchip of the amount received by them.  Neither Microchip nor any other Released Persons shall have any obligations with respect to Plaintiffs' Counsel's fees and&#47;or expenses beyond the Fee and Expense Amount.   </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Plaintiffs&#8217; Counsel shall allocate the Fee and Expense Amount among themselves.  Plaintiffs&#8217; Counsel agree that any disputes regarding the allocation of the Fee and Expense Amount among them shall be presented to and be mediated by the Mediator, and if mediation is unsuccessful, decided on a final, binding, non-appealable basis by the Mediator, on the terms and subject to the processes and procedures set forth by the Mediator in his sole discretion.  The </font></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">- 7 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mediator&#8217;s fees and costs for any such mediation and&#47;or arbitration shall be borne solely by Plaintiffs&#8217; Counsel, and split evenly among Plaintiffs&#8217; Counsel.  Defendants and Defendants&#8217; Counsel shall have no responsibility for the allocation or distribution of the Fee and Expense Amount amongst Plaintiffs&#8217; Counsel.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;Plaintiffs intend to request that the Court approve service awards for Plaintiffs Reid and Dutrisac not to exceed $5,000 each, in recognition of the time and effort each has contributed to the litigation.  Defendants agree not to oppose the request for service awards for Plaintiffs, which will be paid out of the Settlement Amount.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">G.&#160;&#160;&#160;&#160;Conditions of Settlement&#59; Effect of Disapproval, Cancellation, or Termination</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;The Effective Date shall be conditioned on the occurrence of all of the following events&#58;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Court has entered the Judgment, substantially in the form of Exhibit B attached hereto&#59; and</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The Judgment has become Final.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;If any of the conditions specified in Section IV, G.1 are not met, then the Stipulation of Settlement shall be canceled  and terminated  subject to the provisions of this Section IV, G.2, unless counsel for the Settling Parties mutually agree in writing to proceed with an alternative or modified Stipulation and submit it for Court approval.  If for any reason the Effective Date does not occur, or if this Stipulation is terminated, cancelled, or otherwise fails to become effective for any reason&#58;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;the Settling Parties, Released Persons, and Related Parties shall be restored to their respective positions that existed immediately prior to the date of execution of this Stipulation&#59;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;all negotiations, proceedings, documents prepared, and statements made in connection with this Stipulation shall be without prejudice to the Settling Parties, shall not be deemed or construed to be an admission by a Settling Party of any act, matter, or proposition and shall not be used in any manner for any purpose (other than to enforce the terms remaining in effect) in any subsequent proceeding in the Actions or in any other action or proceeding&#59; and</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;the terms and provisions of the Stipulation&#8212;with the exception of the provisions of Section H.4 and Section H.11&#8212;shall have no further force and effect with respect to the Settling Parties and shall not be used in the Actions or in any other proceeding for any purpose, and any judgment or orders entered by the Court in accordance with the terms of the Stipulation shall be treated as vacated, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">nunc pro tune.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;No order of the Court or modification or reversal on appeal of any order of the Court concerning the amount of attorneys' fees, costs, expenses, and interest awarded by the Court to Plaintiffs' Counsel shall constitute grounds for cancellation or termination of the Stipulation, affect the enforceability of the Stipulation, or delay or preclude the Judgment from becoming Final.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">H.&#160;&#160;&#160;&#160;Miscellaneous Provisions</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">1.&#160;&#160;&#160;&#160;The Settling Parties (a) acknowledge that it is their intent to consummate the terms and conditions of this Stipulation&#59; and (b) agree to cooperate to the extent reasonably necessary to effectuate and implement all terms and conditions of the Stipulation and to exercise their best efforts to accomplish the foregoing terms and conditions of the Stipulation.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">2.&#160;&#160;&#160;&#160;The Settling Parties intend this Settlement to be a final and complete resolution of all disputes between Plaintiffs and Microchip and its stockholders, on the one hand, and the Released Persons, on the other hand, arising out of, based upon or related to the Released Claims.  The Settlement compromises claims that are contested and shall not be deemed an admission by any Settling Party or Released Person as to the merits of any claim, allegation, or defense.  The Judgment shall contain a finding that during the course of the litigation, the parties and their respective counsel at all times complied with the requirements of Rule 11 of the Arizona Rules of Civil Procedure and all other similar laws.  The Settling Parties further agree that the Released Claims are being settled voluntarily after consultation with competent legal counsel and an experienced mediator.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">3.&#160;&#160;&#160;&#160;Pending the Effective Date, the Settling Parties agree not to initiate any proceedings concerning the Released Claims other than those incident to the Settlement itself&#59; provided, however, that Microchip and the Settling Defendants may seek to prevent or stay any other action or claims brought seeking to assert any Released Claims.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">4.&#160;&#160;&#160;&#160;Neither the Stipulation nor the Settlement, including any Exhibits attached hereto, nor any act performed or document executed pursuant to or in furtherance of the Stipulation or the Settlement&#58; (a) is or may be deemed to be or may be offered, attempted to be offered or used in any way as a concession, admission, or evidence of the validity of any Released Claims, or of any fault, wrongdoing, or liability of the Released Persons or Microchip&#59; or (b) is or may be deemed to be or may be used as a presumption, admission, or evidence of, any liability, fault, or omission of any of the Released Persons or Microchip in any civil, criminal, administrative, or other proceeding in any court, administrative agency, tribunal, or other forum.  Neither this Stipulation nor the Settlement shall be admissible in any proceeding for any purpose, except to enforce the terms of the Settlement, and except that the Released Persons may file or use the Stipulation and&#47;or the Judgment in any action that may be brought against them in order to support a defense or counterclaim based on principles of </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">res judicata,</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> collateral estoppel, full faith and credit, release, good faith settlement, standing, judgment bar, or reduction or any other theory of claim preclusion or issue preclusion or similar defense or counterclaim.</font></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">- 8 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5.&#160;&#160;&#160;&#160;All agreements made and orders entered during the course of the Actions relating to the confidentiality of information or sealing of documents shall survive this Stipulation and the Judgment.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">6.&#160;&#160;&#160;&#160;All Exhibits to this Stipulation are material and integral parts hereof and are fully incorporated herein by this reference.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">7.&#160;&#160;&#160;&#160;This Stipulation may be amended or modified only by a written instrument signed by or on behalf of all Settling Parties or their respective successors-in-interest.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">8.&#160;&#160;&#160;&#160;This Stipulation and the Exhibits attached hereto constitute the entire agreement among the Settling Parties and no representations, warranties, or inducements have been made to any Settling Party concerning the Stipulation and&#47;or any of its Exhibits, other than the representations, warranties, and covenants contained and memorialized in such documents.  The Stipulation supersedes and replaces any prior or contemporaneous writing, statement, or understanding pertaining to the Actions and no parole or other evidence may be offered to explain, construe, contradict, or clarify its terms, the intent of the Settling Parties or their counsel, or the circumstances under which the Stipulation was made or executed.  It is understood by the Settling Parties that, except for matters expressly represented herein, the facts or law with respect to which this Stipulation is entered into may turn out to be other than or different from the facts now known to each party or believed by such party to be true&#59; each party therefore expressly assumes the risk of facts or law turning out to be different, and agrees that this Stipulation shall be in all respects effective and not subject to termination by reason of any such different facts or law.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">9.&#160;&#160;&#160;&#160;The Stipulation and the Settlement shall be binding upon, and inure to the benefit of, the successors and assigns of the Settling Parties, the Released Persons, and the Releasing Persons.  The Settling Parties agree that this Stipulation will run to their respective successors-in-interest, and they further agree that any planned, proposed, or actual sale, merger, or change-in-control of Microchip shall not void this Stipulation&#59; provided, however, that if the Company&#8217;s stock is no longer publicly traded in the future, the corporate governance enhancements shall no longer apply.&#160;  The Settling Parties further agree that, in the event of a planned, proposed, or actual sale, merger, or change-in-control of Microchip, they will continue to seek final approval of this Stipulation expeditiously, including, but not limited to, the Settlement terms reflected in this Stipulation and the Fee and Expense Amount.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">10.&#160;&#160;&#160;&#160;Except as otherwise expressly provided herein, all parties, including all Settling Defendants, their counsel, Microchip and its counsel, and Plaintiffs, Plaintiffs' Counsel, and Liaison Counsel shall bear their own fees, costs, and expenses.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">11.&#160;&#160;&#160;&#160;Counsel for the Settling Parties are expressly authorized by their respective clients to take all appropriate actions required or permitted to be taken pursuant to the Stipulation to effectuate its terms and conditions.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">12.&#160;&#160;&#160;&#160;Plaintiffs represent and warrant they have not assigned or transferred, or attempted to assign or transfer, to any Person any Released Claim or any portion thereof or interest therein.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">13.&#160;&#160;&#160;&#160;Each counsel or other Person executing this Stipulation or any of its Exhibits on behalf of any party hereto hereby warrants that such Person has the full authority to do so.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">14.&#160;&#160;&#160;&#160;Any failure by any party to this Stipulation to insist upon the strict performance by any other party of any of the provisions of the Stipulation shall not be deemed a waiver of any of the provisions, and such party, notwithstanding such failure, shall have the right thereafter to insist upon the strict performance of any and all of the provisions of the Stipulation to be performed by such other party.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">15.&#160;&#160;&#160;&#160;The Stipulation and Exhibits may be executed in one or more counterparts.  A faxed or pdf signature shall be deemed an original signature for purposes of this Stipulation.  All executed counterparts including facsimile and&#47;or pdf counterparts shall be deemed to be one and the same instrument.  A complete set of counterparts, either originally executed or copies thereof, shall be filed with the Court.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">16.&#160;&#160;&#160;&#160;This Stipulation shall be binding upon, and inure to the benefit of, the Settling Parties and the Released Persons and their respective successors, assigns, heirs, spouses, marital communities, executors, administrators, trustees in bankruptcy, and legal representatives.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">17.&#160;&#160;&#160;&#160;Without affecting the finality of the Judgment entered in accordance with this Stipulation, the Court shall retain jurisdiction with respect to implementation and enforcement of the terms of the Stipulation and the Judgment, and the Settling Parties hereto submit to the jurisdiction of the Court for purposes of implementing and enforcing the Settlement embodied in the Stipulation and the Judgment and for matters arising out of, concerning, or relating thereto.  In the event that a dispute arises between any of the Settling Parties and&#47;or Released Persons concerning compliance with any term of this Stipulation, the Settling Parties agree that such dispute shall be mediated in good faith before the Mediator.  Only after the Settling Parties and Mr. Meyer determine that mediation of such dispute has failed shall relief be sought through a proceeding before the Court.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">18.&#160;&#160;&#160;&#160;This Stipulation and the Exhibits hereto shall be considered to have been negotiated, executed, and delivered, and to be wholly performed, in the State of Arizona, and the rights and obligations of the Settling Parties to the Stipulation shall be construed and enforced in accordance with, and governed by, the internal substantive laws of the State of Arizona without giving effect to Arizona's choice-of-law principles.</font></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">- 9 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the Settling Parties have caused the Stipulation to be executed, by themselves and&#47;or by their duly authorized attorneys, dated ____________, 2023.</font></div><div style="padding-left:12.6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.567%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58; March 24, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">ROBBINS LLP</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#47;s&#47; Stephen J. Oddo</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">STEPHEN J. ODDO</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BRIAN J. ROBBINS</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">ERIC M. CARRINO</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5060 Shoreham Place, Suite 300</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">San Diego, CA 92122<br>Telephone&#58; (619) 525-3990<br>Facsimile&#58; (619) 525-3991</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">E-mail&#58; brobbins&#64;robbinsllp.com</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160; soddo&#64;robbinsllp.com</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">MCKAY LAW</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MICHAEL C. MCKAY (SBN 023354)</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">7702 East DoubleTree Ranch Road</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Suite 300 </font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Scottsdale, AZ 85258</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Telephone&#58; (480) 681-7000</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Facsimile&#58; (480) 348-3999</font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Attorneys for Plaintiff Michael Reid</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58; March 24, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">JOHNSON FISTEL, LLP</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#47;s&#47; Michael I. Fistel</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MICHAEL I. FISTEL, JR.</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MARY ELLEN CONNER</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">40 Powder Springs Street</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Marietta, GA 30064</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Telephone&#58; (470) 632-6000</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Facsimile&#58; (770) 200-3101</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">E-mail&#58; MichaelF&#64;JohnsonFistel.com</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">DESAULES LAW GROUP</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JONATHAN A. DESSAULES </font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5343 North 16th Street, Suite 200</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phoenix, AZ 85016</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Telephone&#58; (602) 274-5400</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Facsimile&#58; (602) 274-5401</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">E-mail&#58; </font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">FRANK J. JOHNSON</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">501 West Broadway, Suite 800</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">San Diego, CA 92101</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Telephone&#58; (619) 230-0063</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Facsimile&#58; (619) 255-1856</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">E-mail&#58; FrankJ&#64;JohnsonFistel.com</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Attorneys for Plaintiff Richard Dutrisac</font></div></td></tr></table></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">- 10 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div><font><br></font></div></div><div style="padding-left:12.6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:93.567%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Dated&#58; March 24, 2023</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">OSBORN MALEDON, P.A.</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">&#47;s&#47; David B. Rosenbaum</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:0.5pt solid #000000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">DAVID B. ROSENBAUM</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">JOSEPH N. ROTH</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">2929 North Central Ave., 21st Floor</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Phoenix, AZ 85012</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Telephone&#58;</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Facsimile&#58;</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">E-mail&#58; </font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">WILSON SONSINI GOODRICH </font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:100%">&#160;&#160;&#160;&#38; ROSATI</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">KEITH E. EGGLETON</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">650 Page Mill Road</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Palo Alto, CA 94304</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Telephone&#58;  (650) 493-9300</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Facsimile&#58;  (650)493-6811</font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">E-mail&#58;  keggleton&#64;wsgr.com </font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:2.75pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:100%">Attorneys for Defendants</font></div></td></tr></table></div><div><font><br></font></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">- 11 -</font></div></div></div><div id="i543c4edc48754904831da53a767507a1_10"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div><font><br></font></div><div style="text-align:center;text-indent:-58.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IN THE SUPERIOR COURT OF THE STATE OF ARIZONA</font></div><div style="text-align:center;text-indent:-58.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IN AND FOR THE COUNTY OF MARICOPA</font></div><div style="text-align:center"><font><br></font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.474%"><tr><td style="width:1.0%"></td><td style="width:49.730%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.070%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MICHAEL REID, Derivatively on Behalf of MICROCHIP TECHNOLOGY, INC.,</font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="padding-left:4.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Plaintiff,</font></div><div style="padding-left:4.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">v.</font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="padding-left:4.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">STEVE SANGHI, GANESH MOORTHY, J. ERIC BJORNHOLT, L.B. DAY, MATTHEW W. CHAPMAN, WADE F. MEYERCORD, AND ESTHER L. JOHNSON,</font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="padding-left:4.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Defendants, </font></div><div style="padding-left:4.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">-and-</font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="padding-left:4.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MICROCHIP TECHNOLOGY, INC., a Delaware corporation,</font></div><div style="padding-left:4.5pt"><font><br></font></div><div style="padding-left:4.5pt;text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Nominal Defendant.</font></div></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Case No. CV2019-002389</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">NOTICE OF PROPOSED STOCKHOLDER DERIVATIVE SETTLEMENT</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">EXHIBIT A-1</font></div><div><font><br></font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">(Assigned to The Honorable Timothy Thomason)</font></div></td></tr></table></div><div style="margin-top:12pt;padding-right:-2.9pt;text-indent:-58.5pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#91;Caption continued on next page&#93;</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="padding-left:7.25pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">RICHARD DUTRISAC, derivatively on behalf of MICROCHIP TECHNOLOGY INCORPORATED,</font></div><div style="padding-left:7.25pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:7.25pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Plaintiff,</font></div><div style="padding-left:7.25pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">v.</font></div><div style="padding-left:7.25pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:7.25pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">STEVE SANGHI, GANESH MOORTHY, JAMES ERIC BJORNHOLT, MATTHEW&#160;W. CHAPMAN, WADE F. MEYERCORD, ESTHER&#160;L. JOHNSON, L.B. DAY, and KAREN RAPP,</font></div><div style="padding-left:7.25pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:7.25pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Defendants,</font></div><div style="padding-left:7.25pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:7.25pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">and</font></div><div style="padding-left:7.25pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:7.25pt;padding-right:2.75pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">MICROCHIP TECHNOLOGY INCORPORATED, a Delaware corporation,</font></div><div style="padding-left:7.25pt;padding-right:2.75pt"><font><br></font></div><div style="padding-left:7.25pt;padding-right:2.75pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Nominal Defendant.</font></div></td><td colspan="3" style="border-left:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Case No. CV2021-012459</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify"><font><br></font></div><div style="height:36pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="i543c4edc48754904831da53a767507a1_13"></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">TO&#58;&#160;&#160;&#160;&#160;ALL RECORD HOLDERS AND BENEFICIAL OWNERS OF MICROCHIP TECHNOLOGY INCORPORATED (&#34;MICROCHIP&#34; OR THE &#34;COMPANY&#34;) COMMON STOCK AS OF MARCH 24, 2023 (THE &#34;RECORD DATE&#34;). </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PLEASE READ THIS NOTICE CAREFULLY AND IN ITS ENTIRETY.  THIS NOTICE RELATES TO A PROPOSED SETTLEMENT AND DISMISSAL OF THE ABOVE-CAPTIONED STOCKHOLDER DERIVATIVE ACTIONS (THE &#34;ACTIONS&#34;) AND CONTAINS IMPORTANT INFORMATION REGARDING YOUR RIGHTS.  YOUR RIGHTS MAY BE AFFECTED BY THESE LEGAL PROCEEDINGS.  IF THE COURT APPROVES THE SETTLEMENT, YOU WILL BE FOREVER BARRED FROM CONTESTING THE APPROVAL OF THE PROPOSED SETTLEMENT AND FROM PURSUING THE RELEASED CLAIMS.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IF YOU HOLD MICROCHIP COMMON STOCK FOR THE BENEFIT OF ANOTHER, PLEASE PROMPTLY TRANSMIT THIS DOCUMENT TO SUCH BENEFICIAL OWNER.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">PLEASE NOTE THAT THE ACTIONS ARE DERIVATIVE ACTIONS BROUGHT BY STOCKHOLDERS OF THE COMPANY FOR THE BENEFIT OF THE COMPANY, AND THERE IS NO CLAIM FORM BECAUSE NO INDIVIDUAL HAS A RIGHT TO BE COMPENSATED AS A RESULT OF THE SETTLEMENT OF THE ACTIONS.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">THE COURT HAS MADE NO FINDINGS OR DETERMINATIONS CONCERNING THE MERITS OF THE ACTIONS.  THE RECITATION OF THE BACKGROUND AND CIRCUMSTANCES OF THE SETTLEMENT CONTAINED HEREIN DOES NOT CONSTITUTE THE FINDINGS OF THE COURT.  IT IS BASED ON REPRESENTATIONS MADE TO THE COURT BY COUNSEL FOR THE PARTIES.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Notice is hereby provided to you of the proposed settlement (the &#34;Settlement&#34;) of the Actions. This Notice is provided by Order of the Superior Court of the State of Arizona for Maricopa County (the &#34;Court&#34;).  It is not an expression of any opinion by the Court with respect to the truth of the allegations in the Actions or merits of the claims or defenses asserted by or against any party.  It is solely to notify you of the terms of the proposed Settlement and your rights related thereto.  Capitalized terms not otherwise defined shall have the definitions set forth in a written Stipulation of Settlement, dated March __, 2023 (&#34;Stipulation&#34;).  The text of the Stipulation is included with a Form 8-K that was filed with the U.S. Securities and Exchange Commission (the &#34;SEC&#34;) on April 14, 2023, and can be viewed at and&#47;or downloaded at the &#34;SEC Filings&#34; link on the &#34;Investor Relations&#34; page at https&#58;&#47;&#47;www.microchip.com&#47;en-us&#47;about&#47;investors.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">I.&#160;&#160;&#160;&#160;WHY THE COURT HAS ISSUED THIS NOTICE</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Your rights may be affected by the Settlement of the actions styled </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reid v. Sanghi, et al.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Case No. CV2019-002389 (Ariz. Super. Ct.-Maricopa Cnty.), and </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dutrisac v. Sanghi, et al.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">, Case No. CV2021-012459 (Ariz. Super. Ct.-Maricopa Cnty.), filed in the Court on January 22, 2019, and August 5, 2021, respectively.  Plaintiffs Michael Reid and Richard Dutrisac, on behalf of themselves and derivatively on behalf of Microchip&#59; defendants Steve Sanghi, Ganesh Moorthy, J. Eric Bjornholt, L.B. Day, Matthew W. Chapman, Wade F. Meyercord, Esther L. Johnson, and Karen Rapp (together, the &#34;Individual Defendants&#34; or &#34;Settling Defendants&#34;), nominal defendant Microchip (together with Plaintiffs and the Settling Defendants, the &#34;Settling Parties&#34;), have agreed upon terms to settle the above-referenced Actions and have signed the Stipulation setting forth those settlement terms.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June  14, 2023 at 9&#58;00 a.m., a hearing (the &#34;Settlement Hearing&#34;) will be held before the Court, at East Court Building, 101 West Jefferson, Phoenix, Arizona 85003, to determine&#58; (i)&#160;whether the terms of the Settlement are fair, reasonable, and adequate, including the separately negotiated amounts for Plaintiffs' Counsel's attorneys' fees and expenses, and should be finally approved&#59; (ii) whether a final judgment should be entered and the Actions dismissed with prejudice pursuant to the Stipulation&#59; and (iii) such other matters as may be necessary or proper under the circumstances.  The Court has the right to continue or adjourn the Settlement Hearing from time to time, by oral announcement at the hearing or at any adjournment thereof, as well as to change the hearing date, time, or platform (in person, by video or telephone conference) without further notice to Microchip stockholders. Thus, if you are planning to participate in the Settlement Hearing, you should confirm the date, time, and platform before going to the Court, and you may consult the Court&#8217;s calendar and&#47;or Plaintiffs&#8217; Counsel&#8217;s website for any change in date or time of, or platform used for the Settlement Hearing.  The Court may also approve the Settlement, with such modifications as may be agreed to by counsel for the Settling Parties consistent with such Settlement, without further notice to Microchip stockholders.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">II.&#160;&#160;&#160;&#160;THE MICROCHIP DERIVATIVE ACTIONS</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">A.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Reid </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Action</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 22, 2019, plaintiff Reid filed an action captioned, </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reid v. Sanghi, et al.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">,</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Case No. CV2019-002389, in the Superior Court of Arizona for Maricopa County against the Individual Defendants and the Company as nominal defendant (the &#34;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reid</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Action&#34;).  </font></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">- 2 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plaintiff Reid alleges that the Individual Defendants breached their fiduciary duties to Microchip and its stockholders by issuing a series of allegedly materially false and misleading statements regarding the operations and financial performance of Microsemi Corporation (&#34;Microsemi&#34;), a computer chip manufacturer it acquired for $10.15 billion.  The </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reid</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Action also brings a claim against the Individual Defendants for waste of corporate assets and unjust enrichment.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Settling Defendants deny each and every one of the claims and contentions alleged by Plaintiff Reid.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">B.&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Dutrisac</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%"> Action </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On August 5, 2021, plaintiff Dutrisac filed suit on behalf of Microchip in this Court alleging his demand served on the Board on April 13, 2020 was wrongfully refused by the Microchip Board (the &#34;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dutrisac </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Action&#34; and together with the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reid </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Action, the &#34;Actions&#34;).  The </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dutrisac</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Action also alleges that the named Individual Defendants breached their fiduciary duties to Microchip and its stockholders by issuing allegedly materially false and misleading statements related to the Company&#8217;s acquisition of Microsemi, and as to certain of the Individual Defendants, by allegedly trading on material, adverse information related to the Company&#8217;s business.  The </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dutrisac</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Action brings claims against the named Individual Defendants for breach of fiduciary duties, insider selling, corporate waste, unjust enrichment, and contribution and indemnification.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Settling Defendants deny each and every one of the claims and contentions alleged by Plaintiff Dutrisac.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">C.&#160;&#160;&#160;&#160;Denial of Motions to Dismiss</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On March 12, 2021, members of the Audit Committee of Microchip&#8217;s Board of Directors moved to dismiss the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reid</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Action.  After full briefing and oral argument, the Court denied the  motion to dismiss on April 1, 2022.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 28, 2022, members of the Audit Committee of Microchip&#8217;s Board of Directors moved to dismiss the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dutrisac</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Action.  After full briefing and oral argument, the Court denied the motion to dismiss on April 7, 2022.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">D.&#160;&#160;&#160;&#160;Partial Consolidation of the Stockholder Derivative Actions in the Arizona Superior Court</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On January 10, 2023, the Arizona Superior Court entered an Order Granting Joint Stipulation Regarding Partial Consolidation of Derivative Actions.  The Court's Order consolidated the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reid </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">and </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dutrisac </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Actions for the limited purpose of pretrial discovery matters.  The Order further provided that &#34;&#91;d&#93;iscovery shall proceed according to this Court's prior scheduling orders entered in the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reid</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dutrisac</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Actions, and, absent stipulation by the parties or further order by the Court, plaintiffs Michael Reid and Richard Dutrisac (&#34;Plaintiffs&#34;) shall coordinate discovery and be subject to all discovery limitations therein and all disclosure rights and obligations thereunder as if Plaintiffs were a single party.&#34;  The Settling Defendants produced more than 900,000 pages of documents to Plaintiffs' Counsel and the Settling Parties had begun setting deposition dates.  As part of the Settlement, the parties will request that the Court consolidate the </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Reid</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> and </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">Dutrisac</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> Actions for all purposes. </font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">E.&#160;&#160;&#160;&#160;The Mediation</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Settling Parties actively engaged in continued discussions aimed at potential resolution of the Actions.  Specifically, the Settling Parties submitted extensive mediation statements to Robert A. Meyer, Esq. (&#8220;Mr. Meyer&#8221; or the &#8220;Mediator&#8221;) and met for a full-day videoconference mediation session before Mr. Meyer on August 24, 2022.  As a result of the mediation and subsequent arm's-length settlement negotiations overseen by the Mediator that followed, the Settling Parties reached an agreement that, subject to approval of the Court, resolves the Actions and the Released Claims as further described herein.</font></div><div style="padding-left:72pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">F.&#160;&#160;&#160;&#160;The Microchip Board of Directors' Approval of the Settlement</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The members of Microchip's Board of Directors unanimously approved the Settlement on February 21, 2023, and unanimously determined that the Settlement is in the best interests of Microchip and its stockholders.  The Settling Defendants acknowledge that the corporate governance measures detailed herein create substantial benefits for the Company and its stockholders, and the benefits of the Settlement, including the corporate governance enhancements and the $4,000,000 monetary payment to be made by the Company&#8217;s insurer(s) to the Company, were caused by Plaintiffs&#8217; and their counsel&#8217;s commencement and prosecution of the Actions.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">III.&#160;&#160;&#160;&#160;THE SETTLING DEFENDANTS&#8217; DENIALS OF WRONGDOING AND LIABILITY</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Settling Defendants deny each and every one of the claims and contentions alleged by Plaintiffs.  The Settling Defendants expressly deny all allegations of wrongdoing or liability against them, or any of them, or any other current or former Microchip directors or officers, arising out of, based upon, or related to any of the conduct, statements, acts, or omissions alleged, or that could have been alleged, in the Actions.  Without limiting the foregoing, the Settling Defendants deny, among other things, that they or any other current or former Microchip directors or officers breached their fiduciary duties, or any other duty owed to Microchip or its stockholders, or engaged in any wrongdoing whatsoever.  The Settling Defendants further deny that Plaintiffs, Microchip, or Microchip's stockholders suffered any damage or were harmed as a result of any conduct alleged in the Actions or otherwise.  The Settling Defendants have further asserted and continue to assert that at all relevant times, they and all other current or former Microchip directors or officers acted in good faith and in a manner they reasonably believed to be in the best interests of Microchip and its stockholders.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Nonetheless, the Settling Defendants also have taken into account the expense, uncertainty, and risks inherent in any litigation, especially in complex cases like the Actions.  The Settling Defendants are entering into this Settlement solely </font></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">- 3 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">because the Settlement would eliminate the burden and expense of further litigation, and without admitting any wrongdoing or liability whatsoever.  </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IV.&#160;&#160;&#160;&#160;TERMS OF THE PROPOSED DERIVATIVE SETTLEMENT</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection of the Settlement of the Actions, Defendants through their insurer have agreed to pay the total amount of $4 million (the &#34;Settlement Amount&#34;). </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Also in connection with the Settlement of the Actions, the Microchip Board of Directors has approved the implementation of the corporate governance measures detailed below within sixty (60) days following final judicial approval of the proposed settlement by the Court.  Except as otherwise specified, the corporate governance enhancements and internal controls programs described below shall remain in effect for five (5) years from the date of adoption.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Settlement also provides that the Actions and Released Claims shall be fully, finally, and forever compromised, settled, discharged, relinquished, and released, and the Actions shall be dismissed with prejudice as to the Settling Defendants.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Enhancement of Management-Level Disclosure Committee</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Function&#58;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Company shall maintain its management-level Disclosure Committee (&#34;Disclosure Committee&#34;) and adopt a charter for the Disclosure Committee.  The Disclosure Committee will review its charter annually.  Any changes to the Disclosure Committee's charter must be approved by the Certifying Officers (defined below).</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The function of the Disclosure Committee will be to review certain public disclosures made by the Company in its U.S. Securities and Exchange Commission (&#34;SEC&#34;) filings.  The Committee will review the disclosures with respect to whether they&#58;  (i) are accurate, complete, and timely&#59; (ii) fairly present the Company's financial condition, results of operations and cash flows in material respects&#59; and (iii) meet any other applicable laws and stock exchange requirements that are brought to the attention of the Committee.  The Disclosure Committee shall hold regular meetings prior to each Form 10-K and Form 10-Q filing required by the Securities Exchange Act of 1934.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Composition&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Disclosure Committee members shall consist of the Company's Chief Executive Officer (&#34;CEO&#34;), Chief Financial Officer (&#34;CFO&#34;), and the Chief Compliance Officer (&#34;CCO&#34;) (described infra), and other representatives of the Company. Additional committee members may be appointed and&#47;or removed by the CEO and&#47;or CFO (the &#34;Certifying Officers&#34;) at any time.  One member of the Disclosure Committee will be designated the Committee's Chairperson by the Certifying Officers.  The Chairperson shall schedule and preside over meetings.  Any interpretation of the charter or the Disclosure Committee's procedures shall be made by the Disclosure Committee Chairperson.  The Chairperson or the Certifying Officers may retain outside consultants or advisors as appropriate.  The Chairperson will report quarterly to the Audit Committee of the Board.  The Company shall also finalize a formal written charter for the Disclosure Committee, which has been reviewed by Plaintiff&#8217;s Counsel prior to the execution of this Stipulation.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Duties and Responsibilities&#58;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Disclosure Committee shall&#58;</font></div><div style="text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;Establish and maintain policies and procedures designed to ensure that information required to be disclosed by the Company in its filings with the SEC and other information that the Company discloses to the public is recorded, processed, summarized, and reported accurately and timely, including policies and procedures for evaluating periodic disclosures, as well as procedures and policies for periodically assessing the effectiveness of the Company's disclosure controls&#59;</font></div><div style="text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;Participate in the evaluation of the effectiveness of the Company's disclosure controls annually&#59;</font></div><div style="text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;Review drafts of the Company's Form 10-Q and Form 10-K and approve as to form and content materially final versions of the Company's Form 10-Q and Form 10-K filings&#59; </font></div><div style="text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iv)&#160;&#160;&#160;&#160;Provide updates to the Audit Committee, as appropriate, concerning disclosure and related risk factor issues identified by the Disclosure Committee&#59; and </font></div><div style="text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(v)&#160;&#160;&#160;&#160;Provide updates to the Board, as appropriate, to ensure that the Board has sufficient information relevant to the Disclosure Committee's work such that the Board can appropriately discharge its obligations. </font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;In order to execute its responsibilities, the Disclosure Committee shall have full access to all Company books, records, facilities, and employees, including independent auditors.</font></div><div style="text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Acquisition Oversight Reforms  </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In connection with any mergers and acquisitions that are material to the Company (&#34;Acquisition&#34; -- which for purpose of this Section IV shall mean that the acquisition is of a publicly traded company of any size or a private company with a purchase price equal to or greater than 5% of the Company's market capitalization at the time the definitive agreement is signed), management shall do the following&#58;</font></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">- 4 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Present to the Board concerning acquisition priorities for due diligence that address lessons learned from prior acquisitions&#59;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Present to the Board concerning management's analysis of the potential benefits and risks of material acquisitions&#59;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Present to the Board management's analysis and recommendations regarding such acquisition&#59; and</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Following any material acquisition of another company, conduct a &#34;lessons learned&#34; session with the Board and provide periodic updates concerning the status of integration efforts.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company shall adhere to the following policies concerning a potential or actual Acquisition&#58; </font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Insider Trading Compliance Officer shall consult with external counsel with respect to stock trading windows in or around Acquisitions, including during the period from any offering being made through closing.  </font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;For the first quarterly period ending after the closing of an Acquisition, the Company shall disclose the revenue and profit from the business that was acquired.   </font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Enhancements to the Duties and Responsibilities of the Audit Committee</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board shall adopt an updated charter of the Audit Committee that includes provisions, or shall otherwise provide, that&#58;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;The Audit Committee shall be responsible for evaluating disciplinary recommendations for violations of codes of conduct by executive officers and directors, and, together with the Company's independent directors (excepting any independent director who may be the subject of disciplinary review), making final determinations regarding such discipline&#59; </font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;The Company shall have a policy that&#58; </font></div><div style="text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;prohibits executive officers from interfering with or exercising undue influence on any member of the Audit Committee concerning any discoveries or conclusions of any Audit Committee investigation&#59; </font></div><div style="text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;prohibits Company executive officers from requesting information from members of the Audit Committee concerning an Audit Committee's investigation, discoveries, or conclusions&#59; and</font></div><div style="text-align:justify;text-indent:108pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;requires that all Company executives cooperate with Audit Committee investigations, and that any failure to cooperate may be grounds for discipline by the Board, including, but not limited to, termination, in the sole discretion of the Board&#59;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;The Audit Committee shall receive a report from the Company's management and the Company's independent auditors regarding the financial statements included in the Company's Form 10-K and Form 10-Q&#59; and</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;The Audit Committee shall receive quarterly reports from the Company's CCO.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Appointment of Chief Compliance Officer</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Microchip shall appoint a CCO (who need not be an executive officer).  The CCO shall work with senior management (including the General Counsel) on matters of corporate compliance, ethics, and governance.  The CCO shall assume primary responsibility for oversight and administration of the Company's corporate governance policies (including the Code of Business Conduct and Ethics, and Corporate Governance Guidelines), coordinating with other senior executives in fostering a culture that integrates compliance and ethics into business processes and practices, and maintaining and monitoring a system for reporting and investigating potential compliance and ethics concerns.  The CCO will assist the Audit Committee and the Board in fulfilling their oversight duties with respect to the Company's compliance with applicable laws and regulations.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The CCO's responsibilities shall include&#58;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Managing and overseeing the Company's Corporate Governance Guidelines&#59;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Serving on the Company's Disclosure Committee&#59;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Retaining independent third-party advisors as appropriate&#59;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;Working with the Company's General Counsel to evaluate the adequacy of the Company's legal and regulatory compliance&#59; and</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;Overseeing executive training in risk assessment, compliance, and public and internal communications, and facilitating and overseeing the training of new Board members.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Director Term Limits</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">No non-employee director shall serve as a member of the Board for a period of time exceeding seventeen (17) years.  This term shall be implemented within one (1) year from the date such terms are agreed to and shall be maintained for no less than twenty (20) years.  This term shall apply to all non-employee directors on the Board as of the Effective Date&#59; however, it will not be retroactively applied (i.e., for current directors, years served before the implementation of this requirement do not count toward the 17 years.)</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Lead Independent Director</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In the event the Chair of the Board is not an &#34;independent director&#34;, the Board shall appoint a Lead Independent Director who satisfies such independence.  The Lead Independent Director may receive such additional compensation for his or her services as the Board of the Company may determine.  The Lead Independent Director shall have the following responsibilities&#58;</font></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">- 5 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;To review Board meeting agendas in advance of each meeting and Board meeting schedules to ensure sufficient time for discussion of agenda items&#59;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;To consult and collaborate with the non-independent Chair as appropriate&#59;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;Chair any executive sessions of the Board which occur outside the presence of the non-independent Chair, the CEO and any other members of management then serving on the Board&#59;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;To call meetings of independent directors at any time he or she deems appropriate&#59;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;To chair Board meetings when the non-independent Chair is not present&#59; </font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;To retain outside advisors in connection with the performance of these duties as he or she deems appropriate&#59; and </font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;To perform such other duties as the Board may deem appropriate from time to time.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Enhanced Director Independence</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Board shall revise the Company's Bylaws and Corporate Governance Guidelines to require three-fourths of the directors (rounded down) of the Board be &#34;independent&#34; as defined by the Nasdaq Stock Market, Inc. (e.g., for a seven-person board, five directors must be independent).</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If the Company fails to comply with the independence requirements set forth herein due to one or more vacancies of the Board, or if one or more directors cease to be independent due to circumstances beyond their reasonable control, Microchip shall within 180 days regain compliance with these requirements.</font></div><div style="padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">Board Self Evaluation</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company's Corporate Governance Guidelines shall be revised to provide for mandatory evaluation of the effectiveness of the Board's governance and oversight procedures in a process designed and approved by the Nominating, Governance and Sustainability Committee, which shall consider NACD or other sources of guidance regarding governance best practices.  The evaluation process shall address the adequacy and timeliness of information and advisory resources made available to Board members&#59; the adequacy of time provided to members for fact-finding, consultations with management, and deliberations&#59; and the Chairperson's effectiveness, among other matters.  The Nominating, Governance and Sustainability Committee will review the results and prepare recommendations for improvements to the whole Board and any relevant committees.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">V.&#160;&#160;&#160;&#160;PLAINTIFFS' COUNSEL SEPARATELY NEGOTIATED ATTORNEYS' FEES AND EXPENSES</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">After negotiating and agreeing upon the principal terms of the Settlement, Plaintiffs' Counsel and Microchip, acting by and through its counsel, with the assistance of the Mediator, separately negotiated the attorneys' fees and expenses the Company would pay to Plaintiffs' Counsel.  In light of the substantial benefits conferred by Plaintiffs' Counsel's efforts, Microchip has agreed not to oppose a fee and expense award of up to $3 million, consisting of (i) 30 percent of the $4 million Settlement Amount, or $1.2 million, subject to Court approval&#59; and (ii) $1.8 million from Microchip, in connection with the corporate governance measures, which the Company agrees to pay subject to Court approval (the &#34;Fee and Expense Amount&#34;).</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plaintiffs intend to request that the Court approve service awards for Plaintiffs Reid and Dutrisac not to exceed $5,000 each, in recognition of the time and effort each has contributed to the litigation.  Defendants have agreed not to oppose the request for service awards for Plaintiffs, which will be paid out of the Settlement Amount.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VI.&#160;&#160;&#160;&#160;REASONS FOR THE SETTLEMENT</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Settling Parties have determined that it is desirable and beneficial that the Action and all of the disputes related thereto is fully and finally settled in the manner and upon the terms and conditions set forth in the Stipulation, and Plaintiffs&#8217; Counsel believe that the Settlement is in the best interests of the Settling Parties, Microchip, and its stockholders.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.&#160;&#160;&#160;&#160;Why Did Lead Plaintiff Agree to Settle&#63;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Plaintiffs and Plaintiffs' Counsel believe that the claims asserted in the Actions have merit.  Plaintiffs and Plaintiffs' Counsel recognize and acknowledge the expense and length of continued proceedings necessary to prosecute the Actions against the Settling Defendants through motion practice, trial, and potential appeals.  Plaintiffs and Plaintiffs' Counsel also have taken into account the uncertain outcome and the risk of any litigation, especially in complex actions such as the Actions, as well as the difficulties and delays inherent in such litigation.  Plaintiffs and Plaintiffs' Counsel also are mindful of the inherent problems of proof of, and possible defenses to, the claims asserted in the Actions.  Based on their evaluation, Plaintiffs and Plaintiffs' Counsel have determined that the Settlement set forth in this Stipulation is in the best interests of Microchip and its stockholders.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;Why Did the Settling Defendants Agree to Settle&#63;</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">As set forth in Section III, the Settling Defendants deny each and every one of the claims and contentions alleged by Plaintiffs.  The Settling Defendants have further asserted and continue to assert that at all relevant times, they and all other current or former Microchip directors or officers acted in good faith and in a manner they reasonably believed to be in the </font></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">- 6 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">best interests of Microchip and its stockholders.  Nonetheless, the Settling Defendants also have taken into account the expense, uncertainty, and risks inherent in any litigation, especially in complex cases like the Actions.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Therefore, the Settling Defendants have determined that it is desirable and beneficial that the Actions, and all of the Settling Parties' disputes related thereto, be fully and finally settled in the manner and upon the terms and conditions set forth in the Stipulation.  Pursuant to the terms of the Stipulation, the Stipulation, including all of the commitments and undertakings agreed to by the Settling Defendants, and all attached Exhibits thereto, shall in no event be construed as or deemed to be evidence of an admission or concession by the Settling Defendants with respect to any claim of fault, liability, wrongdoing, or damage whatsoever.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VII.&#160;&#160;&#160;&#160;SETTLEMENT HEARING</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On June 14, 2023, at 9&#58;00 a.m., the Court will hold the Settlement Hearing at East Court Building, 101 West Jefferson, Phoenix, Arizona 85003.  At the Settlement Hearing, the Court will consider whether the terms of the Settlement are fair, reasonable, and adequate and thus should be finally approved, whether the separately negotiated Fee and Expense Amount should be approved, and whether the Action should be dismissed with prejudice pursuant to the Stipulation.  The Court has the right to continue or adjourn the Settlement Hearing from time to time, by oral announcement at the hearing or at any adjournment thereof, as well as to change the hearing date, time, or platform (in person, by video or telephone conference) without further notice to Microchip stockholders. Thus, if you are planning to participate in the Settlement Hearing, you should confirm the date, time, and platform before going to the Court, and you may consult the Court&#8217;s calendar and&#47;or Plaintiffs&#8217; Counsel&#8217;s website for any change in date or time of, or platform used for the Settlement Hearing.  The Court may also approve the Settlement, with such modifications as may be agreed to by counsel for the Settling Parties consistent with such Settlement, without further notice to Microchip stockholders.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pending determination of whether the Settlement should be approved, no Microchip stockholder, either directly, representatively, derivatively, or in any other capacity, shall commence or prosecute against any of the Released Persons, any action or proceeding in any court, administrative agency, or other tribunal asserting any of the Released Claims.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">VIII.&#160;&#160;&#160;&#160;RIGHT TO ATTEND SETTLEMENT HEARING</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Microchip stockholders as of the Record Date may, but are not required to, appear in person at the Settlement Hearing.  If you want to be heard at the Settlement Hearing, then you must first comply with the procedures for objecting, which are set forth below.  The Court has the right to change the hearing date or time without further notice.  Thus, if you are planning to attend the Settlement Hearing, you should confirm the date and time before going to the Court.  Microchip stockholders who have no objection to the Settlement do not need to appear at the Settlement Hearing or take any other action.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">1.&#160;&#160;&#160;&#160;Right to Object to the Proposed Derivative Settlement and Procedures for Doing So</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any Microchip stockholder who held stock as of March 24, 2023 may appear and show cause, if he, she, or it has any reason why the Settlement of the Actions should not be approved as fair, reasonable, and adequate, or why a judgment should not be entered thereon, or why separately negotiated attorneys' fees and expenses should not be approved.  You must object in writing, and you may request to be heard at the Settlement Hearing.  If you choose to object, then you must follow these procedures.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">2.&#160;&#160;&#160;&#160;You Must Make Detailed Objections in Writing</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any objections must be presented in writing and must contain the following information&#58;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;Your name, legal address, and telephone number&#59;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;Proof of being a Microchip stockholder as of the Record Date&#59;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;The date(s) you acquired your Microchip shares&#59;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;A statement of your position with respect to the matters to be heard at the Settlement Hearing, including a statement of each objection being made&#59;</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(e)&#160;&#160;&#160;&#160;Notice of whether you or your counsel intend to appear at the Settlement Hearing (appearance is not required if you have lodged your objection with the Court)&#59; and</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(f)&#160;&#160;&#160;&#160;Copies of any papers you or your counsel intend to submit to the Court, along with the names of any witness(es) you intend to call to testify at the Settlement Hearing and the subject(s) of their testimony.</font></div><div style="text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(g)&#160;&#160;&#160;&#160;The Court may not consider any objection that does not substantially comply with these requirements.</font></div><div style="padding-left:57.6pt;text-align:justify;text-indent:-21.6pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">3.&#160;&#160;&#160;&#160;You Must Timely Deliver Written Objections to the Court and Counsel for Plaintiffs, Defendants, and Microchip</font></div><div style="padding-left:57.6pt;text-align:justify"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">YOUR WRITTEN OBJECTIONS MUST BE ON FILE WITH THE CLERK OF THE COURT NO LATER THAN MAY 31, 2023.  The Court Clerk's address is&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">- 7 -</font></div></div></div><hr style="page-break-after:always"><div style="min-height:49.68pt;width:100%"><div><font><br></font></div></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Clerk of the Superior Court for Maricopa County</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">201 West Jefferson</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Phoenix, AZ 85003</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">YOU ALSO MUST DELIVER COPIES OF THE MATERIALS TO PLAINTIFFS' COUNSEL AND TO COUNSEL FOR DEFENDANTS AND MICROCHIP SO THEY ARE RECEIVED NO LATER THAN MAY 31, 2023.  Counsel's addresses are&#58;</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Plaintiffs' Counsel&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">STEPHEN J. ODDO</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ERIC M. CARRINO</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">ROBBINS LLP</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">5060 Shoreham Place, Suite 300</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">San Diego, CA 92122</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Or</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MICHAEL I. FISTEL, JR.</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">MARY ELLEN CONNER</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">JOHNSON FISTEL LLP</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">40 Powder Springs Street</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Marietta, GA 30064</font></div><div><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-style:italic;font-weight:700;line-height:120%">Counsel Defendants and Microchip&#58;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">KEITH E. EGGLETON</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">WILSON SONSINI GOODRICH </font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#38; ROSATI, P.C.</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">650 Page Mill Road</font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Palo Alto, CA 94304</font></div><div style="margin-top:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Unless the Court orders otherwise, your objection will not be considered unless it is timely filed with the Court and delivered to Plaintiffs' Counsel and Counsel for Defendants and Microchip.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Any Person or entity who fails to object or otherwise request to be heard in the manner prescribed above will be deemed to have waived the right to object to any aspect of the Settlement as incorporated in the Stipulation and waived any right to otherwise request to be heard (including the right to appeal) and will be forever barred from raising such objection or request to be heard in this or any other action or proceeding, and shall be bound by the releases given and the Judgment to be entered by the Court.</font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="padding-left:36pt;text-align:justify;text-indent:-36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:700;line-height:120%">IX.&#160;&#160;&#160;&#160;HOW TO OBTAIN ADDITIONAL INFORMATION</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This Notice summarizes the Stipulation.  It is not a complete statement of the events of the Actions or the Settlement contained in the Stipulation.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">You may inspect the Stipulation and other papers in the Action at the Court Clerk's office at any time during regular business hours of each business day.  The Clerk's office is located at 201 West Jefferson, Phoenix, AZ 85003.  You or your counsel must appear in person to inspect these documents.  The Clerk's office will not mail copies to you.  You may also view and download the Stipulation on the &#34;Investor Relations&#34; page of Microchip's website at https&#58;&#47;&#47;www.microchip.com&#47;en-us&#47;about&#47;investors.</font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If you have any questions about matters in this Notice you may contact by telephone Plaintiffs' Counsel at (619) 525-3990 or in writing at Stephen J. Oddo, 5060 Shoreham Place, Suite 300, San Diego, CA 92122 or </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">soddo&#64;robbinsllp.com</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> or at (470) 632-6000 or in writing at Michael I. Fistel, Jr., 40 Powder Springs Street, Marietta, GA 30064 or </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">michaelf&#64;johnsonfistel.com</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%">. </font></div><div style="text-align:justify;text-indent:36pt"><font><br></font></div><div style="text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> PLEASE DO NOT CALL, WRITE, OR OTHERWISE DIRECT QUESTIONS TO EITHER THE COURT OR THE CLERK'S OFFICE.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:91.228%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:0 1pt"></td><td colspan="3" style="border-bottom:0.5pt solid #000000;border-left:0.5pt solid #000000;border-right:0.5pt solid #000000;border-top:0.5pt solid #000000;padding:2px 1pt 2px 3.77pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:10pt;font-weight:400;line-height:100%">BY ORDER OF THE SUPERIOR COURT OF THE STATE OF ARIZONA</font></td></tr></table></div><div style="text-align:justify"><font><br></font></div><div><font><br></font></div><div style="height:49.5pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:11pt;font-weight:400;line-height:100%">- 8 -</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>mchp-20230414.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:cc2fc762-edf7-48fe-a50d-a2ddf87cd639,g:ae4f47c7-dfca-4233-8087-a9a33399c5b9-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:mchp="http://www.microchip.com/20230414" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.microchip.com/20230414">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2022" schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mchp-20230414_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="mchp-20230414_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="COVERPAGE" roleURI="http://www.microchip.com/role/COVERPAGE">
        <link:definition>0000001 - Document - COVER PAGE</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>mchp-20230414_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:cc2fc762-edf7-48fe-a50d-a2ddf87cd639,g:ae4f47c7-dfca-4233-8087-a9a33399c5b9-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_EntityTaxIdentificationNumber_6a77e4bd-7073-48a8-ab1a-d5978a64cb21_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_1bc27f40-f000-45aa-8563-e042c0e21f22_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_945621b9-2577-412b-be49-478521d40938_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_f9bfad35-1a75-4299-822f-5fdcf05fb3fa_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_63d4132a-8a2b-4683-8e67-fbec03457acd_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_2636e953-b677-4588-ae9e-d4873defa842_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_a5dda5d7-b28b-4952-a1dc-e1d8b4e0c1f6_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_e7f811ff-9142-4329-8fa4-39887c5f0a5a_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_e2738684-c74a-4455-9e09-ad2446f3f211_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_c1590f98-ffda-4e60-a823-6aee2049fe46_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_a9ca363a-4f84-4bb2-9afc-08d9e519ad2d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_1b22546e-73cd-4851-ad2d-1c31e950c4d2_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_f1c0da44-e4e2-48ec-aa37-a407e09854c8_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_b9e32d1e-13fc-4b38-9d63-602dd02f1dc4_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_b28b0462-c335-4adb-9fc1-227836b5f7aa_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_28afe7f5-b83f-4b76-90bf-704b4b3c6459_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_876874eb-00e1-447e-82b5-eeb3cee35e2c_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SecurityExchangeName_4da9bbf1-b273-4d0b-99ba-1d33ed7dcadc_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_70ff50ed-ef70-4862-b9b0-1bdda5c963de_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_dfbcc2ac-10f6-41ba-931e-3ad20e6faa13_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_f6860296-d0af-4b25-82eb-557c348b14e7_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_92d2d094-4971-46f4-b05c-30c54412c2ab_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_c54e0701-e8b5-47fd-ab67-be4d0b8c2ac3_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>mchp-20230414_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with Wdesk from Workiva-->
<!--Copyright 2023 Workiva-->
<!--r:cc2fc762-edf7-48fe-a50d-a2ddf87cd639,g:ae4f47c7-dfca-4233-8087-a9a33399c5b9-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.microchip.com/role/COVERPAGE" xlink:type="simple" xlink:href="mchp-20230414.xsd#COVERPAGE"/>
  <link:presentationLink xlink:role="http://www.microchip.com/role/COVERPAGE" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_7e1e32ef-f998-4383-a745-e08d86c56073" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_c30474ad-1c72-4229-891c-bc7bcce7bfa0" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7e1e32ef-f998-4383-a745-e08d86c56073" xlink:to="loc_dei_DocumentType_c30474ad-1c72-4229-891c-bc7bcce7bfa0" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_b9f67d07-73bd-4ddd-9765-2ea557edf5f3" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7e1e32ef-f998-4383-a745-e08d86c56073" xlink:to="loc_dei_DocumentPeriodEndDate_b9f67d07-73bd-4ddd-9765-2ea557edf5f3" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_7be74f03-b9d1-4e6e-8788-f89d91e88f7b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7e1e32ef-f998-4383-a745-e08d86c56073" xlink:to="loc_dei_EntityRegistrantName_7be74f03-b9d1-4e6e-8788-f89d91e88f7b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_58a5ce14-7e7d-4619-b9d0-110fc1837ecd" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7e1e32ef-f998-4383-a745-e08d86c56073" xlink:to="loc_dei_EntityCentralIndexKey_58a5ce14-7e7d-4619-b9d0-110fc1837ecd" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_c0a5e25a-5ea7-4808-9542-3582d75d11b7" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7e1e32ef-f998-4383-a745-e08d86c56073" xlink:to="loc_dei_AmendmentFlag_c0a5e25a-5ea7-4808-9542-3582d75d11b7" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_4f15f784-2e80-4f65-89ad-e50dd0e27af8" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7e1e32ef-f998-4383-a745-e08d86c56073" xlink:to="loc_dei_EntityIncorporationStateCountryCode_4f15f784-2e80-4f65-89ad-e50dd0e27af8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_29716563-74f5-4b67-8592-1b6d8adb3ebb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7e1e32ef-f998-4383-a745-e08d86c56073" xlink:to="loc_dei_EntityFileNumber_29716563-74f5-4b67-8592-1b6d8adb3ebb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_6c700f00-6755-40a0-bcd9-d2eff05c551b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7e1e32ef-f998-4383-a745-e08d86c56073" xlink:to="loc_dei_EntityTaxIdentificationNumber_6c700f00-6755-40a0-bcd9-d2eff05c551b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_433e922e-fcfc-4da7-91e9-cd3c33b07792" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7e1e32ef-f998-4383-a745-e08d86c56073" xlink:to="loc_dei_EntityAddressAddressLine1_433e922e-fcfc-4da7-91e9-cd3c33b07792" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_85bd2a75-f33a-4497-920e-84125425e356" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7e1e32ef-f998-4383-a745-e08d86c56073" xlink:to="loc_dei_EntityAddressCityOrTown_85bd2a75-f33a-4497-920e-84125425e356" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_5c74ed65-b45d-4c30-888d-0827bdb9e08d" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7e1e32ef-f998-4383-a745-e08d86c56073" xlink:to="loc_dei_EntityAddressStateOrProvince_5c74ed65-b45d-4c30-888d-0827bdb9e08d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_a7b1d421-1b2e-4582-9d20-441396312637" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7e1e32ef-f998-4383-a745-e08d86c56073" xlink:to="loc_dei_EntityAddressPostalZipCode_a7b1d421-1b2e-4582-9d20-441396312637" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_b356ebad-591a-42fe-8071-cd8ea541679e" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7e1e32ef-f998-4383-a745-e08d86c56073" xlink:to="loc_dei_CityAreaCode_b356ebad-591a-42fe-8071-cd8ea541679e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_9350f2bc-3b06-4339-a084-b3fd5fc8b9eb" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7e1e32ef-f998-4383-a745-e08d86c56073" xlink:to="loc_dei_LocalPhoneNumber_9350f2bc-3b06-4339-a084-b3fd5fc8b9eb" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_75983452-a6c9-4170-b416-5c7f9d2773f9" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7e1e32ef-f998-4383-a745-e08d86c56073" xlink:to="loc_dei_WrittenCommunications_75983452-a6c9-4170-b416-5c7f9d2773f9" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_aa00355a-3a67-4c0d-8b6b-fef5b8ff7c27" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7e1e32ef-f998-4383-a745-e08d86c56073" xlink:to="loc_dei_SolicitingMaterial_aa00355a-3a67-4c0d-8b6b-fef5b8ff7c27" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_c9014774-d579-4292-a404-c8d287842828" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7e1e32ef-f998-4383-a745-e08d86c56073" xlink:to="loc_dei_PreCommencementTenderOffer_c9014774-d579-4292-a404-c8d287842828" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_637f6310-70be-4d64-9985-42b652425646" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7e1e32ef-f998-4383-a745-e08d86c56073" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_637f6310-70be-4d64-9985-42b652425646" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_eca18550-b5df-4bd9-b51a-221c1c27dc35" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7e1e32ef-f998-4383-a745-e08d86c56073" xlink:to="loc_dei_Security12bTitle_eca18550-b5df-4bd9-b51a-221c1c27dc35" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_3b19b981-f613-4cfe-8032-a050e0155ef5" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7e1e32ef-f998-4383-a745-e08d86c56073" xlink:to="loc_dei_TradingSymbol_3b19b981-f613-4cfe-8032-a050e0155ef5" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_21afcc5d-8b70-488d-8861-504aba7ca221" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7e1e32ef-f998-4383-a745-e08d86c56073" xlink:to="loc_dei_SecurityExchangeName_21afcc5d-8b70-488d-8861-504aba7ca221" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_6f928630-7aae-4957-bb70-6ace895f153b" xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_7e1e32ef-f998-4383-a745-e08d86c56073" xlink:to="loc_dei_EntityEmergingGrowthCompany_6f928630-7aae-4957-bb70-6ace895f153b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>mchp-20230414_g1.jpg
<TEXT>
begin 644 mchp-20230414_g1.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_X1#T17AI9@  34T *@    @ ! $[  (
M   .   (2H=I  0    !   (6)R=  $    <   0T.H<  <   @,    /@
M   <Z@    @
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M                                                 $1E8F]R82Y.
M;W)R:7,   60 P "    %   $*:0!  "    %   $+J2D0 "     S8U  "2
MD@ "     S8U  #J'  '   (#   ")H     '.H    (
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
M
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MUM?8V=KAXN/DY>;GZ.GJ\?+S]/7V]_CY^O_$ !\!  ,! 0$! 0$! 0$
M   ! @,$!08'" D*"__$ +41  (! @0$ P0'!00$  $"=P ! @,1! 4A,082
M05$'87$3(C*!"!1"D:&QP0DC,U+P%6)RT0H6)#3A)?$7&!D:)B<H*2HU-C<X
M.3I#1$5&1TA)2E-455976%E:8V1E9F=H:6IS='5V=WAY>H*#A(6&AXB)BI*3
ME)66EYB9FJ*CI*6FIZBIJK*SM+6VM[BYNL+#Q,7&Q\C)RM+3U-76U]C9VN+C
MY.7FY^CIZO+S]/7V]_CY^O_:  P# 0 "$0,1 #\ ^D:*** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHH
MH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
M HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "
MBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **
M** "BBB@ HHHH ***9--%;PM-/(D42#+.[!54>I)Z4 DWHA]%>=^(?C+H&D[
MX=*#ZM<#C,1VQ#_@9Z_@#]:\SUOXL^*=8++#=KIT)Z)9C:?^^_O?D17)4Q=*
M&E[GT&#X>QV)7,X\J[O3\-SZ%O\ 5=/TJ+S-3OK>T3^]/*J9_,UR>H?%[PA8
M9"7TMXX_AMH6/ZM@?K7SI//-<S-+<2O+(W+/(Q8G\34=<<L?-_"K'TM#A/#Q
MUK3<O33_ #/;+OX\V*$_8-$N)AV,TZQ_R#5DS_'C5&/^CZ-9QC/_ "TD9_Y8
MKRFBL'BZSZGJPX>RV'_+N_JW_F>EM\=/$A8[;#2@,\ Q2'_V>G1_'3Q""?-T
M_3&';:D@_P#9S7F5%3]9K?S&_P#8N7?\^D>M6_QYOE(^U:';R>OESLG\P:V;
M/X[:/(0+_2KRWSWB99 /SVUX915+%UEU.>IP[EL_^7=O1O\ S/IS3/B7X2U4
MJL.L10R'^"Y!BQ^+ #]:Z>*6.:)9(761&&59#D$?6OCRM#2M>U;0Y?,TG4+B
MT.<D12$*WU'0_C71#'O[:/&Q'"5-J^'J->3U_%6_)GUM17A_A_XXZA;;8O$=
MDE['T,]OA)/J5^Z?PVUZQX=\5Z1XJM&GT:Y\WR\"6-E*O&3TR#]#STXKOIXB
MG5^%ZGRF-RG&8'6K'W>ZU7_ ^=C8HHHK<\H**\UUWXLR'6KS1O!&D)K-S8OY
M5Y?7-TMM96LG/R&1OOOP?E'H?0XJ_P#"T_$.@?Z5XR\-VLFB[PLNK:#>B[CM
ML]Y$QN ]_P!#0!ZI14-I=V]_9PW=E-'/;SH)(I8VW*ZD9!!'4$5-0 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 44
M44 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !111
M0 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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MXZKS[K_+S/I:BD5@ZAD(92,@@]12U[I^4A1110 4444 %%%% !1110 4444
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M4444 %%%% !1110 4444 %%%% !1110 4444 %%%% &5XFUV'PWX;O-5N,'R
M(_D0G[[GA5_$D5\JWU[<:E?SWMY(9)YY#)(Y[DG->H?''Q%]HU2UT"W?]W:@
M3W !ZR,/E!^B\_\  J\HKQ<95YY\JV1^G\-8!8?"^WDO>GK\NGW[_<%%%%<)
M]2%%%% !7OGPC\#_ -B:8-;U.+%_>)^Z5AS#$?Y%NOTP/6N%^%'@?_A(M8_M
M348MVF63_=8<3R=0ON!U/X#O7T)7IX*A_P O)?(^$XFS6W^Q4G_B_P O\_\
MAPHHHKU3X(*SM=T6U\0Z'<Z7?KF&X3;D=4/4,/<'!K1HI-)JS*A.4)*<79H^
M2-;T>ZT#6KG3+]=LUN^TGLP[,/8C!JA7OGQ@\&_VSHW]MV$>;ZP3]Z%',D/4
M_BO7Z9]J\#KY^O2=*?+T/V'*<PCC\,JGVEHUY_\ !"BBBL#U0J_HFC7>OZS;
M:9IZ;YYWVCT4=V/L!DU0Z]*^AOA7X'_X1K1_[0U"+&IWJ@L&',,?4)]3P3^
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M0?Q._P"AF_\ )"V_^-T ?;5%?$O_  T'\3O^AF_\D+;_ .-U]?\ @K4+K5_
M/A_4M0E\Z[O-,MIYY-H7>[Q*S'   R2> ,4 ;=%%<7\1OBCH/PVTQ9=5=KB^
MG4FVL(3^\EQW/]U<_P 1_ $\4 =I17QMXD_:1\=ZU,ZZ9<0:);-D+':1!GQ[
MNX)S[KMKCI_B=XZN)-\GC#7 ?^F>H2H/R4@4 ??5%? '_"Q_&_\ T.7B#_P:
M3_\ Q5'_  L?QO\ ]#EX@_\ !I/_ /%4 ??]%? '_"Q_&_\ T.7B#_P:3_\
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MCKP)_NZE,H_(-BF_\+'\;_\ 0Y>(/_!I/_\ %4 ??]%? '_"Q_&__0Y>(/\
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MGM7.?&+Q#JGA7X3ZSK.@W/V6_MO(\J;RU?;NGC0_*P(/RL1R.] ';T5\2_\
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M _9*_P"05XG_ .NUO_Z#)7O^I?\ (*N_^N+_ /H)H _.6BBB@ HHHH ****
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M]=I/_13U]R4 %%%% !7EO[1O_)$M4_Z[6_\ Z-6O4J\M_:-_Y(EJG_7:W_\
M1JT ?%U%%% 'Z$>"O^1!\/\ _8,MO_12UR/[0?\ R0GQ#_V[?^E,5==X*_Y$
M'P__ -@RV_\ 12UR/[0?_)"?$/\ V[?^E,5 'Q+1110!];?LJ?\ )+-2_P"P
MU+_Z(@KTGXC_ /)+/%?_ &!;S_T0]>;?LJ?\DLU+_L-2_P#HB"O2?B/_ ,DL
M\5_]@6\_]$/0!\ 4444 %%%% !1110 4444 %?3_ .R_X^FU"PN_!VISF1[)
M/M%@7//E9P\?_ 201[,>PKY@KNO@KJ[:-\9/#LRMA9[H6K#^\)08P/S8'\*
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M& !=103D#L3&JG\RI/XT >85Z7^SU,8OCEH2@@"1;A&S_P!>\A_F!7FE=_\
M O\ Y+;X<_Z[2?\ HIZ /N2OSHUB9KC7+^:3[\ES(S8]2Q-?HO7YN$YY/6@
MKK_ACX"N/B+XV@T6*5K>V5#/=SJ,F.)< X]R2%'N<]JY"OI#]DFQ4OXHOV +
M@6T*'N ?,+?R7\J /7='^#O@#1+1((/"^GW.U<&2^A%P['U)?//TQ6E_PKCP
M1_T)OA__ ,%<'_Q-=)10!S?_  KCP1_T)OA__P %<'_Q-'_"N/!'_0F^'_\
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MMU9CBYE R2/2O1?^$<T/_H#:?_X"I_A7$?L^?\D)\/?]O/\ Z4RUZ30!F_\
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MG_HIZ /N2OS<K](Z_-R@ KZ;_9*_Y!7B?_KM;_\ H,E?,E?3?[)7_(*\3_\
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M#_XJO@"B@#[_ /\ A8_@C_H<O#__ (-(/_BJ/^%C^"/^AR\/_P#@T@_^*KX
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M7]J!@07,D8 &,;6(Z?A5.@#V7]EZ\^S?%J:'/%UIDL>/<.C_ /LIKZ^KXB^
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M&_#;_H+W'_@#+_\ $T >I45Y;_PT;\-O^@O<?^ ,O_Q-'_#1OPV_Z"]Q_P"
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M$!CN+<M@3Q-]Y<]N@(/8@?2@#[]HKRG2_P!I#X=7UHLMYJ5SIDI'S0W-G(S
M_6,,/UJ[_P -!_#'_H9O_)"Y_P#C= 'I-%>;?\-!_#'_ *&;_P D+G_XW1_P
MT'\,?^AF_P#)"Y_^-T >DT5YM_PT'\,?^AF_\D+G_P"-T?\ #0?PQ_Z&;_R0
MN?\ XW0!Z317FW_#0?PQ_P"AF_\ )"Y_^-UZ+;7$5W:Q7-NV^&9!)&V",J1D
M'!]J /E;]J[_ )'[1O\ L&?^U7KPFO=OVKO^1^T;_L&?^U7KPF@#KOA9H&G^
M*/B=HVC:S$TUE=RNLJ*Y0D"-F'(Y'(%?4?\ PSE\-O\ H$7'_@=+_P#%5\V_
M O\ Y+;X<_Z[2?\ HIZ^Y* /+?\ AG+X;?\ 0(N/_ Z7_P"*H_X9R^&W_0(N
M/_ Z7_XJO4J* /+?^&<OAM_T"+C_ ,#I?_BJX3XR_!KP7X.^&-]K.@Z=-!>P
MRPJCM=2. &D53P3CH:^C:\M_:-_Y(EJG_7:W_P#1JT ?%U%%% 'Z$>"O^1!\
M/_\ 8,MO_12UR/[0?_)"?$/_ &[?^E,5==X*_P"1!\/_ /8,MO\ T4M<C^T'
M_P D)\0_]NW_ *4Q4 ?$M%%% 'UM^RI_R2S4O^PU+_Z(@KTGXC_\DL\5_P#8
M%O/_ $0]>;?LJ?\ )+-2_P"PU+_Z(@KTGXC_ /)+/%?_ &!;S_T0] 'P!111
M0 45WOAKX*^-O%OAZVUO0]-AFL;K?Y4C74:$[7*'@G(Y4UJ_\,Y?$G_H$6__
M ('1?_%4 >6T5ZE_PSE\2?\ H$6__@=%_P#%4?\ #.7Q)_Z!%O\ ^!T7_P 5
M0!Y;17J7_#.7Q)_Z!%O_ .!T7_Q5.C_9P^([R!6TNUC!_B:]CP/R)- 'E=?2
M_P"RUX'E@AO_ !C?PE!.OV2PW#[RYS(X]L@*#[-5+P5^RU>&_BNO'6H6ZVJ,
M&-C8NS-+_LM)@;1Z[<GT(ZU])65E;:=8P65C"D%M;QB.**,85% P * )Z***
M "BBB@ HHHH *\V^-FDR7_A2SNK>-I);:[50JC)*R#;@?\"V5Z33719!AU5A
MD'!&>0<@_GS6=2'M(.+ZG7@L5+"8B%>*ORLY#X<>"D\(: #<*IU*Z >Y?KL]
M(Q[#/XG/M78T44X04(J,3/$8BIB:LJU5W;"BBBK, HHHH *X#XS6$5U\/I;E
MPOF6<\<B-WY;81_X]^GM7?UX_P#&WQ5#]GB\-6CAIBZS79'\  ^5?J<Y_ >M
M<^)DE2=SV,DI5*F84O9]'=^BW_R/&:***^?/V ]<^"_C+R+@^&=0D_=RDO9,
MQ^ZW5D_'J/?/K7M5?'D,TEO<1SP.8Y8V#HZG!5@<@BOIWP'XLC\7>&8KPD"[
MB_=748_A<#KCT/4?EVKU\%6YE[-]#\ZXFRSV53ZW36DM_)]_G^?J=-1117HG
MQ@4444 %%%% 'SS\6?!O_"/:_P#VC8Q;=.U!BP"CB*7JR_0]1^([5Y_7UCXD
MT&U\3:!<Z7>C"3+\KXR8W'W6'T/^%?*M[:O8:A<6DK(SP2-&S(VY25."0>XX
MKP\71]G/F6S/U+AW,GC,/[*?QPT]5T?Z,2SNY]/OH;NSE,4\#B2-UZJP.0:^
MH_!_B:#Q9X:@U*':LI&RXB!_U<@ZCZ=Q[$5\K5V?PS\8_P#"*>)%6Z<C3KS$
M=P#T0_PO^!Z^Q-+"UO93L]F7G^6?7</SP7OQU7FNJ_R\SZ3HI 0P!!R#R".]
M+7NGY4%%%% !1110!C^*O#MOXI\.W.EW6%\P;HI,?ZN0?=;_ #V)%?+6HV%S
MI6I7%C?1F.XMY#'(I[$?T]Z^O:\T^)OPZD\2ZA8ZEI*A;EI$M[OWC)P)/^ ]
M_;Z5P8R@YKFCNCZOAW-5A*CH5G:$OP?_  ?\A_P3T1M/\(S:C*NV349MRY'6
M-,JOZE_SKTBH+&RAT[3[>SM5V0V\:QQKZ*!@5/772A[."CV/ QV)>+Q,Z[^T
M_P .GX!1116AQF5XHO/[.\(:Q>D@?9K">;)[;8V/?Z5^>-?>'Q?O/L/P>\3R
MYQNL'A_[^?)_[-7P?0 5ZM^S=:?:?C38RXS]EM9Y>F<90I^'WZ\IKW#]E6U\
MWXE:E<L,B'2G ]BTL?\ 0&@#ZSHHHH 1E#*58 @C!!'6O@CXF>$G\$_$/5=&
M,;);QS&2U)'WH7^9,'O@'!]P:^^*\]^+/PFL/B9H\9$JV>L6BG[+=E<@@_\
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MKYDKZ;_:U_Y!7AC_ *[7'_H,=?,E !7W_P##C_DEGA3_ + MG_Z(2O@"OO\
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M_13U]R4 %%%% !7EO[1O_)$M4_Z[6_\ Z-6O4J\M_:-_Y(EJG_7:W_\ 1JT
M?%U%%% 'Z$>"O^1!\/\ _8,MO_12UR/[0?\ R0GQ#_V[?^E,5==X*_Y$'P__
M -@RV_\ 12UR/[0?_)"?$/\ V[?^E,5 'Q+1110!];?LJ?\ )+-2_P"PU+_Z
M(@KTGXC_ /)+/%?_ &!;S_T0]>;?LJ?\DLU+_L-2_P#HB"O2?B/_ ,DL\5_]
M@6\_]$/0!\ 4444 ?;7[/G_)"?#W_;S_ .E,M>DUYM^SY_R0GP]_V\_^E,M>
MDT %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%5[^^MM
M,T^>]OI5BMX$+R.W8"C8<4Y.RW,+QUXN@\'^'GNVVO>2Y2UA/\;^I]AU/X#O
M7S)=W4]]>2W5W*TT\SEY)&ZLQ.2:VO&?BNY\7^(9;^;*0+\EM#GB-.WXGJ3_
M /6KGZ\'$U_:RTV1^LY)E:P%"\_CEO\ Y?+\PHHHKE/>"NH^'_BU_"/B:.Y=
MF-E/B*[0<Y3/WL>H//YCO7+T549.,E)&->A#$4I4JBNGH?8<4L<\*2PNKQR*
M&5E.0P/((I]>3_!CQE]KLSX;U"3,UNI>T9C]^/NGU7J/;Z5ZQ7T-*HJD%)'X
MWC\'/!8B5"?3;S71A1116IPA1169XAUVT\-Z%<ZI?']W N0@/,C=E'N32;25
MV7"$JDU""NWHCD?BOXV_X1S1?[-T^3&I7R$ J>88^A;ZGH/Q/:OGJM#7-9N_
M$&M7.IZ@^Z:=]V,\(.RCV XK/KY^O6=6=^A^O93ET<OPRI_:>K?G_D@HHHK
M]<][^#WC+^U]'.AW\F;VQ3]R6/,D/0?BO3Z8]Z]+KY'T75[K0=:MM3L&VSV[
MAAZ,.ZGV(R/QKZGT#6K7Q%H=MJEBV8KA,[2>4;NI]P>*]K!UN>/*]T?F/$>6
M?5:_MZ:]R?X/_@[_ 'FC1117<?*A1110 4444 %%%% !1110!R_Q'\)3>.O
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M %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
M444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !11
M10 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%%
M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 8JE-HNEW/-QIMG*<Y_>0*W\Q5VBDTGN5&4HN\78QV\(>&V8LW
MA[2B2<DFRCY_\=I4\)>'(V#1^']+5AT(LHP1^E:]%+DCV-?K-?\ G?WLJ6^E
M:?:8^RV%K#CIY<*KC\A5NBBFDEL92E*3NW<****9(4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
M4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110
M 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !
M1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%
M%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 444
D4 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110!__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>7
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.1</span><table class="report" border="0" cellspacing="2" id="idm140646032393168">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>COVER PAGE<br></strong></div></th>
<th class="th"><div>Apr. 14, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Apr. 14,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">MICROCHIP TECHNOLOGY INCORPORATED<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000827054<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">0-21184<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">86-0629024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">2355 West Chandler Boulevard<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Chandler<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">AZ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">85224-6199<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">480<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">792-7200<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock, $0.001 par value per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">MCHP<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>mchp-20230414_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="mchp-20230414.xsd" xlink:type="simple"/>
    <context id="i829a3695c8e54b839f595b7e5e02de3f_D20230414-20230414">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000827054</identifier>
        </entity>
        <period>
            <startDate>2023-04-14</startDate>
            <endDate>2023-04-14</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey
      contextRef="i829a3695c8e54b839f595b7e5e02de3f_D20230414-20230414"
      id="f-21">0000827054</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag
      contextRef="i829a3695c8e54b839f595b7e5e02de3f_D20230414-20230414"
      id="f-22">false</dei:AmendmentFlag>
    <dei:DocumentType
      contextRef="i829a3695c8e54b839f595b7e5e02de3f_D20230414-20230414"
      id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate
      contextRef="i829a3695c8e54b839f595b7e5e02de3f_D20230414-20230414"
      id="f-2">2023-04-14</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName
      contextRef="i829a3695c8e54b839f595b7e5e02de3f_D20230414-20230414"
      id="f-3">MICROCHIP TECHNOLOGY INCORPORATED</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode
      contextRef="i829a3695c8e54b839f595b7e5e02de3f_D20230414-20230414"
      id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber
      contextRef="i829a3695c8e54b839f595b7e5e02de3f_D20230414-20230414"
      id="f-5">0-21184</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber
      contextRef="i829a3695c8e54b839f595b7e5e02de3f_D20230414-20230414"
      id="f-6">86-0629024</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1
      contextRef="i829a3695c8e54b839f595b7e5e02de3f_D20230414-20230414"
      id="f-7">2355 West Chandler Boulevard</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown
      contextRef="i829a3695c8e54b839f595b7e5e02de3f_D20230414-20230414"
      id="f-8">Chandler</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince
      contextRef="i829a3695c8e54b839f595b7e5e02de3f_D20230414-20230414"
      id="f-9">AZ</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode
      contextRef="i829a3695c8e54b839f595b7e5e02de3f_D20230414-20230414"
      id="f-10">85224-6199</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode
      contextRef="i829a3695c8e54b839f595b7e5e02de3f_D20230414-20230414"
      id="f-11">480</dei:CityAreaCode>
    <dei:LocalPhoneNumber
      contextRef="i829a3695c8e54b839f595b7e5e02de3f_D20230414-20230414"
      id="f-12">792-7200</dei:LocalPhoneNumber>
    <dei:WrittenCommunications
      contextRef="i829a3695c8e54b839f595b7e5e02de3f_D20230414-20230414"
      id="f-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial
      contextRef="i829a3695c8e54b839f595b7e5e02de3f_D20230414-20230414"
      id="f-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer
      contextRef="i829a3695c8e54b839f595b7e5e02de3f_D20230414-20230414"
      id="f-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer
      contextRef="i829a3695c8e54b839f595b7e5e02de3f_D20230414-20230414"
      id="f-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="i829a3695c8e54b839f595b7e5e02de3f_D20230414-20230414"
      id="f-17">Common Stock, $0.001 par value per share</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="i829a3695c8e54b839f595b7e5e02de3f_D20230414-20230414"
      id="f-18">MCHP</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="i829a3695c8e54b839f595b7e5e02de3f_D20230414-20230414"
      id="f-19">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany
      contextRef="i829a3695c8e54b839f595b7e5e02de3f_D20230414-20230414"
      id="f-20">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>9
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M4D9CS$*XK7LG70PYAS^:_P!02P,$%     @ %XN.5B0>FZ*M    ^ $  !H
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M_0QI-^2!8ECFS_A[QA?_&\[Q$<+NOS^QO-9.&G_FB^$_7G\!4$L! A0#%
M  @ %XN.5@=!36*!    L0   !               ( !     &1O8U!R;W!S
M+V%P<"YX;6Q02P$"% ,4    "  7BXY6@($.H^X    K @  $0
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M<R\N<F5L<U!+ 0(4 Q0    ( !>+CE; T9W-.@$  "<"   /
M  "  6L0  !X;"]W;W)K8F]O:RYX;6Q02P$"% ,4    "  7BXY6)!Z;HJT
M  #X 0  &@              @ '2$0  >&PO7W)E;',O=V]R:V)O;VLN>&UL
M+G)E;'-02P$"% ,4    "  7BXY699!YDAD!  #/ P  $P
M@ &W$@  6T-O;G1E;G1?5'EP97-=+GAM;%!+!08     "0 ) #X"   !%
"   !

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>10
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="mchp-20230414.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - COVER PAGE</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.microchip.com/role/COVERPAGE</Role>
      <ShortName>COVER PAGE</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" original="mchp-20230414.htm">mchp-20230414.htm</File>
    <File>exhibit991-noticeofpropose.htm</File>
    <File>mchp-20230414.xsd</File>
    <File>mchp-20230414_lab.xml</File>
    <File>mchp-20230414_pre.xml</File>
  </InputFiles>
  <SupplementalFiles>
    <File>mchp-20230414_g1.jpg</File>
  </SupplementalFiles>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>14
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "instance": {
  "mchp-20230414.htm": {
   "axisCustom": 0,
   "axisStandard": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 22
   },
   "contextCount": 1,
   "dts": {
    "inline": {
     "local": [
      "mchp-20230414.htm"
     ]
    },
    "labelLink": {
     "local": [
      "mchp-20230414_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "mchp-20230414_pre.xml"
     ]
    },
    "schema": {
     "local": [
      "mchp-20230414.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd"
     ]
    }
   },
   "elementCount": 23,
   "entityCount": 1,
   "hidden": {
    "http://xbrl.sec.gov/dei/2022": 2,
    "total": 2
   },
   "keyCustom": 0,
   "keyStandard": 22,
   "memberCustom": 0,
   "memberStandard": 0,
   "nsprefix": "mchp",
   "nsuri": "http://www.microchip.com/20230414",
   "report": {
    "R1": {
     "firstAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mchp-20230414.htm",
      "contextRef": "i829a3695c8e54b839f595b7e5e02de3f_D20230414-20230414",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     },
     "groupType": "document",
     "isDefault": "true",
     "longName": "0000001 - Document - COVER PAGE",
     "menuCat": "Cover",
     "order": "1",
     "role": "http://www.microchip.com/role/COVERPAGE",
     "shortName": "COVER PAGE",
     "subGroupType": "",
     "uniqueAnchor": {
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "baseRef": "mchp-20230414.htm",
      "contextRef": "i829a3695c8e54b839f595b7e5e02de3f_D20230414-20230414",
      "decimals": null,
      "first": true,
      "lang": "en-US",
      "name": "dei:DocumentType",
      "reportCount": 1,
      "unique": true,
      "unitRef": null,
      "xsiNil": "false"
     }
    }
   },
   "segmentCount": 0,
   "tag": {
    "dei_AmendmentFlag": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.",
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag"
       }
      }
     },
     "localname": "AmendmentFlag",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.microchip.com/role/COVERPAGE"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_CityAreaCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Area code of city",
        "label": "City Area Code",
        "terseLabel": "City Area Code"
       }
      }
     },
     "localname": "CityAreaCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.microchip.com/role/COVERPAGE"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_CoverAbstract": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Cover page.",
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]"
       }
      }
     },
     "localname": "CoverAbstract",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "xbrltype": "stringItemType"
    },
    "dei_DocumentPeriodEndDate": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.",
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date"
       }
      }
     },
     "localname": "DocumentPeriodEndDate",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.microchip.com/role/COVERPAGE"
     ],
     "xbrltype": "dateItemType"
    },
    "dei_DocumentType": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.",
        "label": "Document Type",
        "terseLabel": "Document Type"
       }
      }
     },
     "localname": "DocumentType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.microchip.com/role/COVERPAGE"
     ],
     "xbrltype": "submissionTypeItemType"
    },
    "dei_EntityAddressAddressLine1": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name",
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One"
       }
      }
     },
     "localname": "EntityAddressAddressLine1",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.microchip.com/role/COVERPAGE"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressCityOrTown": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the City or Town",
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town"
       }
      }
     },
     "localname": "EntityAddressCityOrTown",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.microchip.com/role/COVERPAGE"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressPostalZipCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Code for the postal or zip code",
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code"
       }
      }
     },
     "localname": "EntityAddressPostalZipCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.microchip.com/role/COVERPAGE"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityAddressStateOrProvince": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the state or province.",
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province"
       }
      }
     },
     "localname": "EntityAddressStateOrProvince",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.microchip.com/role/COVERPAGE"
     ],
     "xbrltype": "stateOrProvinceItemType"
    },
    "dei_EntityCentralIndexKey": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.",
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key"
       }
      }
     },
     "localname": "EntityCentralIndexKey",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.microchip.com/role/COVERPAGE"
     ],
     "xbrltype": "centralIndexKeyItemType"
    },
    "dei_EntityEmergingGrowthCompany": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Indicate if registrant meets the emerging growth company criteria.",
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company"
       }
      }
     },
     "localname": "EntityEmergingGrowthCompany",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.microchip.com/role/COVERPAGE"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_EntityFileNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.",
        "label": "Entity File Number",
        "terseLabel": "Entity File Number"
       }
      }
     },
     "localname": "EntityFileNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.microchip.com/role/COVERPAGE"
     ],
     "xbrltype": "fileNumberItemType"
    },
    "dei_EntityIncorporationStateCountryCode": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Two-character EDGAR code representing the state or country of incorporation.",
        "label": "Entity Incorporation, State or Country Code",
        "terseLabel": "Entity Incorporation, State or Country Code"
       }
      }
     },
     "localname": "EntityIncorporationStateCountryCode",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.microchip.com/role/COVERPAGE"
     ],
     "xbrltype": "edgarStateCountryItemType"
    },
    "dei_EntityRegistrantName": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.",
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name"
       }
      }
     },
     "localname": "EntityRegistrantName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.microchip.com/role/COVERPAGE"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_EntityTaxIdentificationNumber": {
     "auth_ref": [
      "r1"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.",
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number"
       }
      }
     },
     "localname": "EntityTaxIdentificationNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.microchip.com/role/COVERPAGE"
     ],
     "xbrltype": "employerIdItemType"
    },
    "dei_LocalPhoneNumber": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Local phone number for entity.",
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number"
       }
      }
     },
     "localname": "LocalPhoneNumber",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.microchip.com/role/COVERPAGE"
     ],
     "xbrltype": "normalizedStringItemType"
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "auth_ref": [
      "r3"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.",
        "label": "Pre-commencement Issuer Tender Offer",
        "terseLabel": "Pre-commencement Issuer Tender Offer"
       }
      }
     },
     "localname": "PreCommencementIssuerTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.microchip.com/role/COVERPAGE"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_PreCommencementTenderOffer": {
     "auth_ref": [
      "r4"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.",
        "label": "Pre-commencement Tender Offer",
        "terseLabel": "Pre-commencement Tender Offer"
       }
      }
     },
     "localname": "PreCommencementTenderOffer",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.microchip.com/role/COVERPAGE"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_Security12bTitle": {
     "auth_ref": [
      "r0"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Title of a 12(b) registered security.",
        "label": "Title of 12(b) Security",
        "terseLabel": "Title of 12(b) Security"
       }
      }
     },
     "localname": "Security12bTitle",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.microchip.com/role/COVERPAGE"
     ],
     "xbrltype": "securityTitleItemType"
    },
    "dei_SecurityExchangeName": {
     "auth_ref": [
      "r2"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Name of the Exchange on which a security is registered.",
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name"
       }
      }
     },
     "localname": "SecurityExchangeName",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.microchip.com/role/COVERPAGE"
     ],
     "xbrltype": "edgarExchangeCodeItemType"
    },
    "dei_SolicitingMaterial": {
     "auth_ref": [
      "r5"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.",
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material"
       }
      }
     },
     "localname": "SolicitingMaterial",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.microchip.com/role/COVERPAGE"
     ],
     "xbrltype": "booleanItemType"
    },
    "dei_TradingSymbol": {
     "auth_ref": [],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Trading symbol of an instrument as listed on an exchange.",
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol"
       }
      }
     },
     "localname": "TradingSymbol",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.microchip.com/role/COVERPAGE"
     ],
     "xbrltype": "tradingSymbolItemType"
    },
    "dei_WrittenCommunications": {
     "auth_ref": [
      "r6"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.",
        "label": "Written Communications",
        "terseLabel": "Written Communications"
       }
      }
     },
     "localname": "WrittenCommunications",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "presentation": [
      "http://www.microchip.com/role/COVERPAGE"
     ],
     "xbrltype": "booleanItemType"
    }
   },
   "unitCount": 0
  }
 },
 "std_ref": {
  "r0": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r1": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "b-2",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r2": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "12",
   "Subsection": "d1-1",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r3": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "13e",
   "Subsection": "4c",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r4": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14d",
   "Subsection": "2b",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r5": {
   "Name": "Exchange Act",
   "Number": "240",
   "Publisher": "SEC",
   "Section": "14a",
   "Subsection": "12",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  },
  "r6": {
   "Name": "Securities Act",
   "Number": "230",
   "Publisher": "SEC",
   "Section": "425",
   "role": "http://www.xbrl.org/2003/role/presentationRef"
  }
 },
 "version": "2.2"
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>15
<FILENAME>0000827054-23-000058-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0000827054-23-000058-xbrl.zip
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M 8UPJK("&* 6[XTS]8DA9?QZ>)8>(3PG!/T AA@EI.32F^X9U 0K.Z@\_TZ
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M_@2F\4VPX'8>3"5LD<GV!V^\T]Y9;W#:&8R!(9_V!OW..3'A]Z/AX,WI$*]
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M8&]#FA*G#-U3@6;S1,8](8/N\,DJ $0GP;-"]0VYIRYTNQB"K%)G:649O=&
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M08,6C"IRFWPH>*YNH"F<VU2-XO4'#B,9)SQ[8XU4K3AV%2_1.^F;T+G/J,\
M=#]^-Z@O0))WM*RDAK.[0_SFKDK>>,Q,LJ4HU]6"[#0Q)\G.7<#;0&1;FAF#
M%Q$X!2<3T(J@OB<1J)4AH+YN[ DNTLT=T6'.6+ NOK/4X)2%(I<XUC0A6S*X
M78GIZM&NHGFTY*4>X+C6F 1$GE@Q(BTM$CJ:MB%Q$J_XO4EZZW'>.&X0@G&7
MVE<Z47&D),.'*'"ITZPI.EM*K3'GIH*2W+!FOITVMW3G'%5JD@F[6)DRCEL[
MD?G99K"^3=K-M<G5!NA ^XG*4=/:.96OA5"+"CK,B?M-#+I*+&,^;7;!G,%N
M$YM^M3X:T<"EFPQJ29,AI[Z.RE*#>F8&DBY,K@?\;*4;;UV.$C-O.[E^2ZBA
M&H2@&_BG-B]TQ?M<HQ"N4EXFC="L9FEL1G#7Y-\FIAHC&"?T!;TC.+H @VJ@
MG@98E6^ALFN!^'!M4WR#Y%M6"\38<,9-&H4K,UCO9(TJW3),.@B%>3A]T,.Z
MJ>B;H1+0V&03.*X%@<Q*.('B5VY,*U7<5\95P.U#J6VG4-J#0P2^?K=X>V?H
MX/H35]3GO:.=Q]^!9(EBR<TL<;5*H>T:R6!@@4*298XIK\:7ZGN3LJ"-PF*Y
M[)#TZT='@ZYF6)Q:+W.+7M22F[A%7&9_KY7-]!H*(UJYL%HB,8YU#*SBOG85
M:QLV\.LB?S72.74SE1Y4M>4\"B(4!/4,V4 K&"@G*X 5MPS#5FU;.[2A>Q\4
M.JC*][*8@[+ZOP:>4PM<QI'2;1XPSUTZGIHBS8'Q#TAA7,3.H'0NK+\?;TPJ
MX8>Z^E;%-!CML08OV*H-:@<3."%^HU/23,6\8.8G\,%"9#"O+)7:X[(>S%[=
MR I?Z%[F:Q-)1\M70B3:DXG^9_9;LZLAS2QZJ^ 3OE6KWQZ:[:&ZJP/1QNJ1
M!1+$-IF.-9;?;#/6G BXDJ1)BWF,_YG<Z8T5'9CT4WGA7-K=D;-:CB+KZ"&(
MNW2KUKP]\-F1-F"H> JTP]@B*PM- 7"L"F.+_$@%*;>#XL0-+B]=?'8C:K<9
MI5I#H, ^13<J:WV0P-:-*;5:?81^DYGZ;A8L6T\8!:+3)'6R'S13#3O7T(Z'
M3(_YKHT':PO06:ZM(JUV_W:3+60.I[@P3 0<@VY.8SB)N9"/%>NDP,[](1(L
MG)&O,"BH.W.M=!V9Y-$UZ:'V*I2W$IELQ/[A&^ Q9C#NVQU]"<Q5"@\IUUN%
MXZE<WU!-;\(P,*V:YL%".:Y/FI\!HF%1@[3Z2-^3>*V>6GQGQTK>IR4[2DA
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MKKW8/?A\Y^"?>@PQ4M49G7JG[\:C_E6GZWMAS9J:K+6F4$D8CBZ'H\ZX=_I
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M+1=#4M=!9BQJM!,#ZW%!NS:!P<5H2*%*CP:C<9CE:A$!IS%X7(TUT[]IST\
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M]@V!BB97N6]F,SO$]IJFE;REI?GVPTD\7,Z0/0:=T$%X&QGJ%-.2WK1&L @
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MKDC=?,/K+V'9?I1"HUQ([MTI)*N.UY9+R\:*UC6M\SQO/1WOMR=7_EY)8Y_
M70CN.MP><->#TXQ^HIQ5:LNX>K=(/O;QE1'@7#VO7\'=DH(&R^%:=4F>5;I@
MCF$ _.8^&-I)RSA96AV4\]%1VUTK_"$K!+7>DV/U&5\DI?%2:MJ26,AZPY54
MF/YLYH(T909W]V]I-V%F2)?N(0J?\<P#ICU)XR7SGB-F$7NJ:ED=8N9%8K'8
M]'FD>;JD5X1TO*L>5Z&$DMC443,2$W  !JJ3D?HZ%MLO12F%H-WB^GT*Z'!
MISJBDT5PU(G;Z'J=]ULD:/RY.EV"#;7[TE%[];U]!ZV9-X0&K]=54)O5=",U
MC(%2')#(R%:,^9,PX'KC5+E!DLK7CY:3*6<+=^N[Z@(5S"GF^C#M!W[$. KG
MD[\=U8@G_X#IHEX?U.O[R&Q4\!7D]H6AF.2L13E7E3DA'^J*4)P9FD&.,:5
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MS%DR>^,7.A:?TJEF773U"<-C,#ROUV%X?AE$HUOX;YS.IK_^#U!+ P04
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M3A17 :L-O4%LH,&:CN6<%)*;)X6DZV[D3VHG/K\A4DT"=IKSN8P#.JF&4<B
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M@1K"M3? 2='C_@C6?9BA_@BF<M8T682@):SS"[-!U[Y1[\\13]V,;&))-N0
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MJ^;W=VW[_60?G6"[Y+/!;U!+ P04    "  7BXY62 S!QFY/   M?@  %
M &UC:' M,C R,S T,31?9S$N:G!G[+P'7%/-UC>Z$1%$-*+2% D"BM([BI"(
M" @(B(B1&A$0 2E2I(:@""A50$11"8((2(E*E1;I3:7W'GI/J"'U;GR>\[[G
M/.?\[G?>K]SOWN\Z,#]F[TQFS5JS9JW_6GLVC#[&&'!05TM'"V!B8@)\P!^
M,7YP7=/'X0X Z.L#8@  L &[F<X#N\#6 ?!"-\P!V VVF<#VS3=O=_X"_ !P
ML&V>'V %[W& US!@Y^;\K^_^+K_+[_*[_"Z_R^_R_]-RR>ZVJ[NUE(&KN[N#
M!P"P/&/^A2>.@+CAP[/=_]$NC8O]U6964@2 N+C_;/\GMF!+VAGO-[;X77Z7
MW^5W^5U^E_]_%SD9V;,J,N#O.4&9<RKRYU04S_W+>R * >R VX KX Y8 U*
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M",T9 V:*,PQ@-VAWOVU<Q,XF*8[@<@8=DOQ<D[T'U(YXVRSNT;^ZT%$92D*
M_&@5H)?V7Y1P]/ZX;P]_#?0JQK@*'K1DWI8Z_W,8(JST/2UQ?(C>V2X-7]5&
MC/_8U5FCLK\R\19.1&_M*W_C3#;4'9VR9%9@A+P0I]M(#4W7N?[ZS?#@$$C;
M5L"<&%^%&S"[2]R#$7#)Z>412Z/9(D?(V-76%.P^[.?CW)=LO3AR9+Y%/E(3
MG\8\H4-<]_HD=+# ^[=\X[HK6#T90%#\-J>5@5(4I@ IOR[ ^WU[8D,EQH1
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MYK'(9/>@>Z+S(;X;/]P80"$\@EXW7@&O+NJX;:EE6#"4J79"8S5X$8FAV%^
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M=^^J=/>&%;987JOZK%BV7#4[\<YX44M3(VNN5T4KZW[&:+U-2;%[=$9OE[]
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M\ (+"D2J$Z!O"($O[K,'7<.ARG]*'EYEC?JW$#]9&_DZ@:S]CV>/;W3A)KE
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MQL:;9T"UQ?\U*2U6_OX)OANWM-199YW:X.,V)&%ZF#0$7.0."%VL$@"GP #
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M4EO?GE/8M6!O#UO0C\B4?W)HOU7>\:+C80>FGX[%-?A53XZROU&0-C0ZW05
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M_@O\]O_R?_E/B<#>Z)\!4$L#!!0    ( !>+CE9\\'CX:PH  $E>   5
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MXP]V_@102P$"% ,4    "  7BXY6&#X(9DF!  !' @, '@
M@ $     97AH:6)I=#DY,2UN;W1I8V5O9G!R;W!O<V4N:'1M4$L! A0#%
M  @ %XN.5LHD6>?+$   UVH  !$              ( !A8$  &UC:' M,C R
M,S T,30N:'1M4$L! A0#%     @ %XN.5MYCC)]R @  ?@<  !$
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8;6Q02P4&      8 !@"2 0  2O8

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
